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Abstract 
 Multinuclear magnetic resonance imaging (MRI) is currently under extensive 
development. Although conventional proton MRI is mostly known as an anatomical medical 
imaging modality with an excellent soft tissue contrast, multinuclear MRI proves that MRI 
can provide researchers and clinicians with information about the internal organs function. 
This class of MRI techniques relies on imaging different nuclei than protons. A large part of 
multinuclear MRI includes fluorine-19 (19F) and hyperpolarized (HP) xenon-129 (129Xe) 
MRI. 19F MRI is used for functional imaging of the lungs, molecular imaging of fluorinated 
biosensors, cell labeling, and drug metabolism investigation. On the other hand, HP 129Xe can 
be used for functional brain imaging along with perfusion imaging of the brain and kidneys. 
 This thesis is focused on the development of HP 129Xe Time-of-Flight (TOF) 
perfusion imaging technique, functional lung imaging using octafluorocyclobutane (OFCB), 
and colorectal adenocarcinoma resistivity detection to 5-fluorouracil (5-FU) using 19F MRI. 
HP 129Xe TOF pulse sequence is capable to map and measure perfusion quantitively was 
developed and evaluated in phantoms and healthy volunteers. As a representative application, 
HP 129Xe TOF perfusion imaging was used to detect hemodynamic response to motor and 
visual stimuli in healthy brains. The performance of OFCB as a contrast agent has been 
evaluated in vitro and in vivo and compared to perfluoropropane, which is the most 
commonly used inhalation agent for 19F lung MRI. Theoretical comparison between both 
gases was conducted as well. Finally, resistivity detection of human colorectal 
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adenocarcinoma to 5-FU was performed using 19F chemical shift imaging to access 
chemotherapy retention in the colorectal cancer.  
 This work expands the arsenal of multinuclear MRI techniques with completely new 
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Chapter 1: Introduction 
 1.1 Diagnostic Imaging 
Nowadays diagnostic imaging is a vital part of any healthcare system. The use of medical 
imaging drastically increased over the past decades3,4 due to the ability of providing 
anatomical and functional information mostly non-invasively. The main pillars of medical 
imaging are the following techniques: ultrasound, computed tomography (CT), positron 
emission tomography (PET),scintigraphy, single photon emission computed tomography 
(SPECT), and magnetic resonance imaging (MRI). Each of these imaging approaches is 
widely used for a variety of purposes from diagnostics to image guided surgeries5–7 and 
biopsies8–10. All medical imaging modalities have some advantages and drawbacks which 
determine the areas of their application. 
 Ultrasound imaging relies on propagation of elastic waves in the human body, with 
frequencies in a range from 1 MHz to 20 MHz11. The image is formed based on the detection 
of the ultrasound waves reflected from the organs back to the transducer12,13. Currently this is 
the most frequently used medical imaging modality after X-rays, and one of the most cost 
efficient. In addition, usually ultrasound imaging systems are easily portable. However, the 
signal-to-noise ratio (SNR) of ultrasound images is generally low due to high distortion of 
sound waves during propagation through tissue and multiple noise sources affecting the 
detected signal11. In addition, the spatial resolution of ultrasound imaging is limited to one 
half of the spatial US wavelength13,14, and usually does not exceed 300 um13. The main 
limitation of ultrasound imaging is the high number of image artifacts as well as difficulties 
of imaging structures behind the bones in the body. 
 CT reconstructs the image from multiple X-ray attenuation projections through the 
body under a variety of angles. The CT image is a tissue density map measured in Hounsfield 
units (HU). The HU value for water is zero, whereas air has a value of −1000.15 High-density 
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objects such as bones appear bright (HU >> 1) whereas low-density structures such as the 
lungs appear dark. Currently, CT images have the highest spatial resolution among all 
medical imaging modalities and it is usually about 30 um16. The main limitation of CT 
imaging is an extremely low contrast in the soft tissues due to their low radio-opacity17. 
Therefore, a variety of a contrast agents are used to overcome this issue. As an example, 
stable isotopes of xenon (Xe) gas are used for ventilation imaging18 of the lungs and 
perfusion imaging19. Since Xe has high atomic number, it provides reasonable CT image 
enhancement, and since Xe easily dissolves in blood it allows further quantification of the 
blood flow20. The main issue associated with CT is the extremely high radiation dose 
delivered to the patient (10-20 mSV)21.  
 PET utilizes the detection of the β+-decay of radiolabeled tracers injected in the body. 
This imaging modality has the highest sensitivity22 due to the absence of natural sources of 
gamma-rays in the living organism and to low attenuation of this type of radiation by the 
human body. Therefore, a small dose of radiopharmaceuticals is needed to achieve the image 
(~10-6 g)23. PET belongs to metabolic activity imaging and molecular imaging modalities. 
The following isotopes are most commonly used for PET imaging: 11C, 18F, 13N, and 15O. 
Although PET is extremely sensitive, the spatial resolution is lower compared to MRI and CT 
medical imaging modalities24,25. The physical limitation of spatial resolution of PET is caused 
by the positron (β+) spread range. For example, the positron traveling range for 18F isotope is 
0.5 mm26. In addition, there are strong time limitations caused by the short half-life of the 
radiolabeled compounds27.  
 SPECT relies on the detection of the γ-rays emitted by radiolabeled tracers (labeling is 
usually performed using 99mTc, 201Tl, 123I, 121I)28. The data acquisition is performed by 
rotating the gamma camera around the patient. For accurate SPECT image reconstruction, the 
number of angular views should be at least equal to the projection image matrix size28. 
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Although SPECT is an extremely sensitive medical imaging modality, the spatial resolution 
of it is even worst compared to PET due to the utilization of a single photon detection 
scheme. Another drawback of SPECT is utilization of ionizing radiation for imaging. SPECT 
is often used for perfusion imaging29–31, molecular imaging32,33, and pulmonary imaging34,35.   
 MRI relies on the detection and localization of nuclear magnetic resonance (NMR) 
signals originating from the subject placed in a strong magnetic field (usually in a range 
between 1.5 and 7.0 T). This medical imaging modality produces images with excellent 
contrast between soft tissues and with a reasonable spatial resolution (~100 um). 
Furthermore, MRI does not involve ionizing radiation. However, MRI has poor sensitivity36. 
The MRI signal is directly proportional to the concentration of the signal nuclei and spin 
population excess at Zeeman energy levels. In conventional clinical MRI, the population 
excess is ~10-5 which significantly limits MRI sensitivity. Clinical MRI mostly detects the 
signal of water protons (1H) in the human body. Although conventional 1H MRI is mostly 
used to provide anatomical information, techniques are also available to functionally image 
the brain37 and lungs38 as well as to image water diffusion39.  
1.2 1H Magnetic Resonance Imaging 
 Conventional MRI was invented in 1973 by Paul Lauterbur40. In his seminal work, the 
first two-dimensional back-projections of water capillary phantoms were acquired. This 
invention revolutionized the field of medical imaging due to its ability to create high-
resolution images, good soft tissue contrast, and absence of harmful ionizing radiation.  
 Conventional MRI relies on Zeeman level splitting41 of thermally polarized 1H nuclei 
energy levels. (The MRI physics will be discussed in detail in Section1.4.) However, the 
population difference of the thermally polarized nuclei is only about 10-5, and the MRI signal 
is proportional to this population excess42. Therefore, the MRI image voxel needs to be large 
enough to enclose numerous 1H nuclei, limiting spatial resolution. The high soft tissue 
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contrast of MRI originates from the different relaxation times of the nuclei in different 
tissues. Therefore, there are variety of techniques, suitable for selective imaging of the 
particular tissues based on the physical properties of the nuclei in that tissue43–45.  
 Although conventional proton MRI is a clinically available imaging modality, it still 
has several challenges which limit its applications. Foremost, it is hard to image organs with 
low proton density like human lungs. In addition, signal voids and artifacts may result if the 
imaging area contains regions with large magnetic susceptibility differences. Human lungs 
are a good example of where tissue/air susceptibility differences yield signal voids on the 
MRI image46–48. Finally, physiological motions cause various image artifacts which should 
be eliminated from the MRI image. Therefore, respiratory and cardiac gating appear 
frequently in a clinical practice49,50 and are essential for cardiac imaging and angiography.  
1.3 Multinuclear Magnetic Resonance Imaging 
 Conventional 1H MRI is a tremendously powerful medical imaging modality, but is 
still mostly known as an anatomical imaging modality with high soft-tissue contrast. On the 
other hand, functional information of the different organs sometimes is a key for a 
successful disease diagnostics and treatment monitoring. In order to acquire functional 
information, numerous techniques were developed for conventional MRI: diffusion-
weighted imaging (DWI), blood oxygenation level dependent (BOLD) functional MRI, 
oxygen-enhanced MRI, etc.  
 Another approach, which demonstrated its capability to obtain information about 
organ function using MRI, relies on imaging different nuclei than protons which can be 
detected in the MRI scanner. 19F, 31P, 129Xe, 3He, and 13C are the most commonly used 
nuclei for MRI imaging and spectroscopy (MRS). Each nucleus emits an MRI signal of a 




  31P MRS/MRI is used often for detection and tracking of high-energy metabolites and 
membrane phospholipids such as adenosine tri-phosphate (ATP), phosphomonoesters 
(PME), glycerophosphocholine (GPC), nicotinamide adenine dinucleotide (NAD), etc51–53 in 
human brains and muscles. 31P MRS is widely used for studying brain tumors54,55, 
Alzheimer’s disease52, diabetes56, and muscle metabolism57–59.  
 The primary application of 19F MRI is functional imaging of the lungs. The detected 
MRI signal is produced by inert fluorinated gases which are used as inhalation contrast 
agents. The inert fluorinated gases are safe for inhalation48,60,61 and are usually mixed with 
oxygen in order to prevent asphyxia46,47,62,63. 19F MRI of the lungs produces ventilation 
images which can be used to calculate regional ventilation parameters such as ventilation 
defect percentage, ventilation volume, and forced exhalated volume during the first second. 
Furthermore, 19F lung MRI allows measuring Apparent Diffusion Coefficient (ADC)64,65 and 
ventilation/perfusion ratio (V/Q)66 which are valuable parameters for diagnosis of 
pulmonary diseases. Currently, the most commonly used gases for functional 19F MRI 
imaging of the lungs are perfluoropropane (PFP)47,61,67,68 and sulfur hexafluoride (SF6)60,69–
71. Recently, octafluorocyclobutane (OFCB) has become of interest in the field of 19F MRI 
imaging72–74. The main relative advantage of inert fluorinated gases is a short spin-lattice 
relaxation time which allows intensive signal averaging during a single breath-hold. In 
addition, inert fluorinated gases can be mixed with oxygen and, therefore, can be used for 
continuous breathing imaging protocols. The main challenge of performing inert fluorinated 
gas MRI is the short effective spin-spin relaxation time which significantly limits the 
amount of signal per acquisition. 
 Besides functional imaging of the lungs, 19F MRI has been used for cell tracking and 
tumor metabolism investigations. The cell labeling can be conducted either in situ, via 
nonspecific uptake of intravenous tracers by phagocytes, or ex vivo, which is the most 
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commonly used approach75. Transfection agents76 and charged lipid incorporation77 are 
commonly used to label living cells (even non-phagocytic cells) with perfluorocarbons 
which can be easily detected in MRI. The main applications of 19F cellular MRI imaging are 
therapeutic cell migration tracking78,79 and visualization of metastatic cancer cell 
distribution80–82.  
 19F MRI is also frequently used to study the metabolism of drugs83. Probably the most 
studied application of 19F MRI for drug metabolism is the detection of 5-fluorouracil (5-
FU)84–86. 5-FU is one of the most commonly used cytotoxic drugs for treatment of different 
types of solid cancers87. It metabolizes primarily in the liver and only a small portion of the 
administrated dosage enters the tumor. There, 5-FU metabolizes to fluorouridine 
triphosphate and fluorodeoxyuridine triphosphate which cause RNA and DNA damage 
respectively. Therefore, it is possible to study 5-FU metabolism and its effect on different 
tumors by monitoring the MRI signal evolution with time. Recently, 19F MRS allowed 
tumor resistivity detection based on 5-FU signal evolution86. 
 Another group of nuclei commonly used in MRI is the noble gases, particularly 3He 
and 129Xe61,88. These nuclei can be hyperpolarized (HP) which substantially increases their 
MRI signal42 (for more information, the reader is referred to Section 1.7). Once polarized, 
3He and 129Xe can be used for functional imaging of the lungs which remains the primary 
application of HP noble gas MRI. Indeed, conventional proton MRI is totally incapable of 
visualizing the lungs due to low proton density in lung parenchyma and large magnetic 
susceptibility mismatch between the lung tissue and the air in the airways. By contrast, after 
inhalation of HP gas, it is possible to acquire an MRI image which represents the gas 
ventilation regions. Similar to inert fluorinated gas MRI mentioned above, the obtained 
ventilation images can be used to obtain local distribution of ventilation defects, ventilation 
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volume, and ADC of the gas which could be recalculated into the alveolar size. It should be 
mentioned, that HP lung MRI images have substantially higher SNR than 19F lung MRI60.  
 HP 3He produces higher SNR than HP 129Xe due to its higher gyromagnetic ratio89. 
HP 129Xe can freely dissolve in the pulmonary blood and, therefore, be used to study gas 
transfer in the lungs and can be used for functional imaging of the highly perfused organs. A 
detailed discussion of HP 129Xe imaging can be found in sections 1.7.3 and 1.7.4.  
 Overall, multinuclear MRI has become more and more popular over the last thirty 
years. Changing MRI signal source nuclei allowed researchers to transfer the MRI imaging 
from the field of mainly anatomical imaging into the area of functional imaging. Despite 
enormous development in the field, there are multiple challenges associated with different 
non-proton imaging techniques. The work presented in this thesis is focused on overcoming 
some of the challenges associated with 19F and HP 129Xe imaging. 
1.4 Physics of Magnetic Resonance Imaging. Nuclear Magnetic Resonance 
 In order to facilitate the discussion of the MRI imaging methodologies developed in 
this thesis, the basic concepts of NMR are described in this section. For more details 
regarding the basic principles of MRI, the readers are referred to “MRI: The Basics, 2rd 
Edition” by Hashemi RH., et al.90. The readers who want to become familiar with advanced 
MRI principles and MRI physics are referred to “Magnetic Resonance Imaging: Physical 
Principles and Pulse Sequence Design” by Haacke et. al91. 
1.4.1 Nuclear Magnetic Moment and Magnetization 
 The nuclei with an odd number of protons and/or neutrons have intrinsic angular 
momentum given by:  
 ,J I=   [1-1] 
where  is the Dirac constant, and I is the nuclear spin. This angular momentum causes the 
nuclear magnetic moment:  
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 .J =  [1-2] 
Here, γ is gyromagnetic ratio, which physically characterizes the ratio of spin magnetic 
moment to the angular momentum and is unique for each nucleus. Since the vast majority of 
MRI techniques utilizes nuclei with a spin quantum number of ½, the ensuing discussion will 
pertain mainly to those nuclei. The gyromagnetic ratios of the most commonly used nuclei 
for MRI imaging are shown in Table 1-1. 
Table 1-1: Gyromagnetic ratios of nuclei with ½ spin that are most commonly used 
for MRI imaging1 








Considering an arbitrary ensemble of N nuclei, it is convenient to describe its magnetic 
properties using the density of magnetic moments or magnetization. The magnetization of the 












This semi-classical approach is convenient for further discussion of the MRI physics. Once 
placed in an external magnetic field, the potential energy of the nuclear magnetic moment is 
defined as: 
 0;E B= −   [1-4] 
where 0B is the magnetic induction vector of the external magnetic field. Substituting Eq. [1-
2] into Eq. [1-4], the following expression of the potential energy can be obtained:  
 0E IB= −  [1-5] 
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The nuclear spin has a value of either ½ or -½. Therefore, in the presence of external 
magnetic field, the spin system can by described by two energy levels (Figure 1-1). The 
lower energy level (or “ground state”) corresponds to the state in which the spin magnetic 
moment is aligned in parallel to the external magnetic field. On the contrary, the higher 
energy level is populated by nuclei with magnetic moment antiparallel to the external 
magnetic field. These two energy levels are degenerate in the absence of the external 
magnetic field. This physical phenomenon is known as Zeeman effect41 or Zeeman energy 
level splitting. The energy gap between the two Zeeman levels is given by: 
 0.E B =  [1-6] 
 







=  [1-7] 











It can be clearly seen that at the thermal equilibrium condition the ground state has an 











where 1N  is the number of spins in the ground state and 2N is the number of spins in the 
higher energy state. Using the Boltzmann equation [1-8] and taking into account that 








  [1-9] 
If we consider the conditions of normal body temperature and the presence of external 
magnetic field of 3T, the polarization of water protons in the body will be approximately 10-5.  











=   [1-10] 
where VN is the number of nuclei per unit volume. 
1.4.2 Magnetization dynamics in an external static magnetic field 
In the presence of the external magnetic field, the magnetization vector experiences a torque: 
 0.B =   [1-11] 
which, by definition, is the change of angular momentum with time: 
 ( ) ( ) ( )0 .
d
J t t B t
dt
=   [1-12] 
Multiplying Eq. [1-12] by the gyromagnetic ratio and taking into account Eqs. [1-2] and [1-




 ( ) ( ) ( )0 .
d
M t M t B t
dt
=   [1-13] 
It can be noted that the magnitude magnetization vector does not change with time according 
to Eq. [1-13]. The vector differential equation [1-13] can be rewritten as a system of scalar 
differential equations known as the phenomenological Bloch equations: 
 
( ) ( ) ( ) ( ) ( )( )
( ) ( ) ( ) ( ) ( )( )
( ) ( ) ( ) ( ) ( )( )
x y z z y
y z x x z
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Assuming 0B vector is aligned along the +z direction and translating to the complex variable 
xy x yM M iM= + , the solution of system [1-14] can be obtained: 
 ( ) 00 0sin , cos
i B t
xy zM M e M M
 −= =  [1-15] 
where zM is the projection of magnetization vector on the z axis and   is the polar angle.  
  Overall, the solution [1-13] describes the precession of the net magnetization about 
the external magnetic field lines. The precession frequency, also known as Larmor frequency, 
can be calculated using the following equation: 
 0 0B =  [1-16] 
  The sign of gyromagnetic ratio determines the direction of the nuclear precession. If 
gyromagnetic ratio is positive, the magnetization precesses clockwise (for example, 1H 
nuclei). On the contrary, the nuclei with a negative gyromagnetic ratio will experience 
counterclockwise nuclear precession (for example, 129Xe nuclei). Since gyromagnetic ratio is 
unique property of each nucleus, the precession frequency will be unique as well. 
1.4.3 Magnetization Dynamics in a Time-Varying Magnetic Field. NMR signal 
  In the previous section, we considered nuclear magnetization dynamics in the 
presence of the static external magnetic field. In order to understand the concept of NMR, the 
12 
 
effect of a time-varying external magnetic field should be elaborated as well. Assuming the 
presence of an additional varying magnetic field ( )1B t which is orthogonal to the static 
magnetic field 0B , the following expression can be written: 
 
 ( )1 1 ,
i tB t B e −=  [1-17] 
Here,  is the frequency of the time-varying magnetic field. Since ( )1B t field is rotating with 
frequency  about z-axis, it is convenient to transform the laboratory frame of reference into 
a reference frame that rotates around the z axis at the same frequency. It is also convenient to 
calculate the net effective magnetic field as follows:  
 01 .eff
B
B B i k 

 
= + − 
 
 [1-18] 
  It can be seen that, in the rotating frame of reference, ( )1B t is static along the abscissa, 
and the applicate component (z component) is reduced by a factor of 

. If ( )1B t has 
frequency equal to the Larmor frequency, the effective magnetic field will be determined 
only by the time-varying magnetic field. Once the spin system described in 1.4.1 is placed in 
such a time-varying magnetic field, the electromagnetic energy will be absorbed by nuclei in 
the ground state. This energy will excite them to the upper energy level. Once the time-
varying ( )1B t field is terminated, the excited nuclei will recover to the Boltzmann 
distribution through the emission of electromagnetic waves at their Larmor frequency. This 
effect is known as NMR.  
  Considering the perfect match between the Larmor frequency and the frequency of the 
varying external magnetic field, Eq. [1-13] can be written as follows: 
 ( ) ( ) ( )1 .
d
M t M t B t
dt
=   [1-19] 
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  Using the direct analogy with Eq. [1-13], the solution of [1-19] describes the rotation 
of the magnetization vector around the 1B  vector. The rotation angle can be calculated using 





 =   [1-20] 
  As can be calculated from the γ values in Table 1-1, the Larmor frequency of the 
nuclei lies in a range of MHz radiofrequencies. Therefore, radiofrequency (RF) pulses are 
used to create the ( )1B t  field in NMR and MRI. The RF pulses are frequently called by the 
rotation angle , or “flip angle” FA, of magnetization that they cause (for instance, a 90O or 
180O pulse). After an RF pulse of FA   has been applied, the magnetization vector position 
















    
    
=    
    −   
 [1-21] 
  Once the RF pulse is terminated, the magnetization rotation around the abscissa is 
terminated as well. However, the net magnetization vector is still precessing around the 
external static magnetic field. If an RF coil is placed orthogonal to the xy-plane (transverse 
plane), the precessing magnetization vector will produce a changing magnetic flux,  , 
through the coil contour. Since the coil surface is orthogonal to the transverse plane, only the
xyM component of magnetization will contribute to the  . The electromotive force induced 
in the coil provides a measurable NMR signal, also known as free induction decay (FID), and 









d t dM r t
S t B r dV
dt dt
 
= − = −   
 
  [1-22] 
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where ( )S t is the NMR signal in volts, r is radius vector, and sV is a sample volume. 
Taking into account that ( ) ( ) 0, i tM r t M r e −= , Eq. [1-22] can be written as: 




S t i e M r B r dV
 −=   [1-23] 
 
 
1.4.4 Spin-lattice Relaxation 
 Spin-lattice relaxation is the physical process that brings the spin system back to 
thermal equilibrium after excitation by the RF pulse. The spin system returns to thermal 
equilibrium through interaction with rapidly fluctuating magnetic fields induced by the 
random motions of magnetic moments. To account for spin-lattice (also known as 
longitudinal or T1) relaxation, the magnetization dynamic equation should be modified as 
follows:  










=  −  [1-24] 







= −  [1-25] 
where ( )zM t is the longitudinal magnetization (the applicate component of magnetization 
vector), 1T  is spin-lattice relaxation time constant, and 0M is magnetization at thermal 
equilibrium. The solution of Eq. [1-25] describes the time evolution of longitudinal 
magnetization: 
 ( ) ( ) 1 100 1 .
t t
T T
zM t M e M e
− − 






 M(0) is the magnetization at  t=0 and itis determined by the FA of the applied RF pulse.  
Therefore, the spin-lattice relaxation of longitudinal magnetization can be described: 
 ( ) ( ) 10 1 1 cos .
t
T
zM t M e
− 




 Generally speaking, T1 relaxation time depends on the physical and chemical environment 
and can vary through the sample. Thus, the signal equation [1-23] must be modified to 
incorporate the effect of spin-lattice relaxation: 










= − − 
 
 
  [1-28] 
The longitudinal magnetization dynamics following a 90O RF pulse is demonstrated in Figure 




Figure 1-2. Longitudinal magnetization regrowth following a 90O RF pulse for four different spin-




  From Figure 1-2 it is possible to notice that longitudinal magnetization fully recovers 
to thermal equilibrium after termination of a 90O RF pulse in approximately 5T1. The 
exponential regrowth of the longitudinal component of net magnetization applies to all MRI 
that utilizes samples at thermal equilibrium. The difference in spin-lattice relaxation time of 
different tissues can be a source of MRI contrast.  
1.4.5 Spin-Spin and Effective Spin-Spin Relaxation 
 Simultaneously with spin-lattice relaxation, the spin-spin relaxation (also known as 
transverse or T2 relaxation) , causes decay of the magnetization component in a transverse 
plane. It originates from interaction between the magnetic moments of neighboring spins in 
the system. This interaction yields a loss in coherence between magnetic moments and thus in 
transverse magnetization destruction. After termination of the RF pulse, the evolution of 






= −  [1-29] 
where T2 is the spin-spin relaxation time constant. The solution of Eq. [1-29] can be written 
as:  
 ( ) ( ) 20 ,
t
T
xyM t M e
−
=  [1-30] 
where ( )0M  is the transverse magnetization immediately following RF pulse termination. 
Besides direct spin-spin interaction, the inhomogeneities of the static magnetic field and the 
local differences in magnetic susceptibility of the sample contribute to transverse 
magnetization decay as well. Therefore, the transverse magnetization decay is characterized 
by effective, or apparent, spin-spin relaxation time ( *2T ) which is shorter than T2 and is given 
by: 
 *
2 2 2 2,
1 1 1 1
B
sT T T T
= + +  [1-31] 
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where *2T  is the effective spin-spin relaxation time constant, 2
BT is the transverse relaxation 
contribution from magnetic field inhomogeneities, and 2,sT describes the contribution of local 
susceptibility differences of the sample. The difference between transverse magnetization 
decay caused by 2T  and *2T  relaxation is exemplified in Figure 1-3. 
 
Eq. [1-28] should be modified to include MRI signal decay owing to apparent spin-spin 
relaxation effects: 
 ( ) ( ) ( ) ( )
( ) ( )*1 20
0 1 1 1 cos
s
tt
T r T ri t
V





= − − 
 
 
  [1-32] 
Similar to spin-lattice effects, spin-spin relaxation varies as a function of coordinates and, 









1.4.6 Spatial localization of the MRI signal. Linear magnetic field gradients 
  Once generated, the MRI signal needs to be localized in order to acquire an MRI 
image. Spatial localization of the MRI signal is implemented through application of the linear 
gradients of the magnetic field. These gradients cause the spatial distribution of the Larmor 
frequencies resulting in specific frequency and phase encoding of the detected MRI signal. 
The magnetic field gradient vector is given as follows:  
 ( )
( ) ( ) ( ) ˆˆ ˆ, .z z z
dB t dB t dB t
G r t i j k
dx dy dz
= + +  [1-33] 
Therefore, the magnetic field in the presence of the linear gradient can be expressed as 
follows: 
 ( ) ( )0 ˆ ˆ, , .x y zB x y z B k G x G y G z k= + + +  [1-34] 
In general, the linear magnetic field gradients cause spatially distributed phase accumulation: 




r t G r rd    =   [1-35] 
It is useful to introduce k-space formalism in a similar way to the wave vectors: 
 ( ) ( )( ) ( ) ( )0, 2 .2
t
r t k t r k t G d

   

 =   =   [1-36] 
Taking into account Eq. [1-36], k-space can be interpreted as a space of the spatial 
frequencies. k-space is a conjugated space which can be transformed into the image space by 
Fourier transform.  
The MRI signal can be expressed in terms of k-space formalism using the following equation: 




0 1 1 .
S
i k rt T r t T ri t
V
S k i e M r B r e e e dV

− − −−
=  −  [1-37] 
The MRI signal ( )S t becomes a function of the position in k-space and is gathered over the 
whole image space. Once the MRI signal is acquired, an MRI image can be reconstructed 
from the k-space using an inverse Fourier transform: 
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M r S k e dk
 
=   [1-38] 
where ( )effM r is an effective magnetization density that contains spin-lattice and spin-spin 
relaxations, RF magnetic field, and the phase effect. The effective magnetization now is a 
function of the image (“real”) space and its distribution is represented as an MRI image.  
  In order to create a k-space prior to image reconstruction, MRI acquires data using 
specific sequences of RF pulses and magnetic field gradients. They are typically referred to 
as pulse sequences. A pulse sequence contains the information about the set of RF pulses, 
gradient waveforms, timing parameters, and signal sampling timing.  
1.4.7 2D Gradient Echo Imaging Pulse Sequence  
  2D gradient echo (GRE) imaging pulse sequence shown in Figure 1 – 4 is one of the 
most commonly used MRI pulse sequences. The GRE pulse sequence can be divided into 
four separate parts: RF pulse, slice-selection, phase encoding, and frequency encoding.  
 
 




  Each pulse sequence begins with an excitation RF pulse to flip the longitudinal 
magnetization into the transverse plane. The time between two subsequent excitation RF 
pulses is called repetition time or TR. Although the flip angle   can be arbitrary, there is a 
trade-off between the spin-lattice relaxation effect and the signal gain from using   flip 











Use of the Ernst angle for the given TR allows SNR maximization. Each RF pulse can be 
characterized by associated bandwidth (BW) or range of processional frequencies that will be 
excited. The RF BW can be calculated by computing a Fourier transform of the RF pulse 
shape. If the RF spectrum of the pulse is infinite (as obtained with a rectangular RF pulse), 
the RF BW is associated with the frequency range containing approximately 95% of RF 
power. Although a RF pulse of arbitrary shape can be used, the excitation pulse is desired to 
have rectangular BW for accurate slice excitation. Therefore, a sinc-shaped RF pulse in the 
time domain is frequently used for spin excitation. 
  In order to excite a 2D slice of spins, the excitation pulse is initiated in the presence of 
a slice-select magnetic field gradient. The slice-select gradient is referred to as the z-gradient 
in Figure 1-4. Conventionally, the applicate axis (z axis) is aligned with the external magnetic 
field 0B . There are three main slice orientations in the MRI depending on the slice-select 
gradient orientation: axial slice (gradient is applied along applicate), coronal (gradient is 
applied along abscissa), and sagittal (gradient is applied along ordinate). The thickness of the 








 =  [1-40] 
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where exBW is the excitation pulse bandwidth, and zG is the strength of the slice-select 
gradient. Generally speaking, there are only two ways of adjusting the slice thickness: either 
changing RF excitation pulse BW or the strength of the slice-select gradient.  
  Following slice selection, the phase encoding is performed. On the pulse sequence 
diagram (PSD), phase encoding gradients are usually applied along ordinate axis (y 
direction). While the phase encoding gradient is on, the nuclear spins of the excited slice 
precess at the Larmor frequency which varies depending on spin location. This causes a 
phase accumulation and once the gradient is terminated, the spins retain the acquired phase. 
The position in k-space after phase encoding is given by: 
 ( ) ,
4y p f s y
k T t t G


= + −  [1-41] 
where 
pT is the duration of the phase encoding gradient, st is the time when the gradient 
strength reaches 
yG , and ft is the time when the current in the gradient coil is terminated. Eq. 
[1-41] assumes the trapezoidal gradient waveform which, in fact, is the most widely used in 
practice.  
  Conventional 2D GRE imaging acquires k-space data line-by-line (Cartesian 
trajectories). A single line of k-space is acquired during each repetition of the GRE pulse 
sequence. In order to do this, the phase encoding gradient strength is different during each 
repetition.  
  Following phase encoding, frequency encoding gradients are applied. The data 
acquisition (ACQ) is triggered in the presence of the frequency encoding gradient. Although 
frequency and phase encoding gradients are interchangeable, traditionally, the frequency 
encoding gradients are depicted along the x-axis on PSDs. The frequency encoding gradient 
in GRE starts with a negative lobe. It causes initial dephasing of the transverse magnetization. 
In order to create an echo, the following lobe of the frequency encoding gradient is positive 
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with a twice larger area under the gradient waveform. The echo occurs during the readout 
where 0xk = , and the time between the excitation pulse and the center of echo (maximum 
signal) is called the echo time (TE). 



























yG is the difference in the magnitude of yG , and sT  is the signal sampling time. 







 =  [1-43] 
1.4.8 Image SNR 
  One of the main characteristics of image quality is SNR. It is defined as the mean 
signal value divided by the standard deviation of the noise.  
  Noise in MRI is caused by the Brownian motion of electrons within the body’s 
conducting tissue92 and is described by the following equation93,94: 
 4 ,n sv kTR f=   [1.44] 
where T is the sample temperature, R is the real part of the input impedance, and Δf is the 
frequency bandwidth. Taking into account Eqn. [1-37], MRI image SNR can be calculated as 
follows:  






i k rt T r t T ri t
Vs
SNR i e M r B r e e e dV
kTR f
 − − −−
=  −

  [1.45] 
The MRI signal is proportional to the Larmor frequency and, therefore, is proportional to B0. 
In addition, the signal is proportional to the magnetization which, on its own, is proportional 
23 
 
to the B0 magnetic field. The combination of these two factors gives the B02 dependance for 
the signal.  
  On the other hand, the frequency of the eddy currents which are caused by the Brownian 
motion of the body’s electrons increases with increasing external magnetic field. Therefore, by 
Faraday’s law of induction, the noise EMF increases in proportion to B0. Thus, the image SNR 
should increase linearly with the strength of the external magnetic field.  
  In practice, however, in order to maintain the chemical shift effect at a constant number 
of pixels, the frequency encoding bandwidth is increased proportional to B0 field92. Therefore, 
the image SNR increases only as B01/2. 
Generally speaking, the image SNR depends on numerous factors such as T1, T2*, TR, TE and 





























SNR x y NSA
BW
   [1-47] 
where ,x yN is the number of phase encodings and readout points respectively, and NSA  is the 
number of signal averages. 
1.4.9 Chemical Shift Imaging 
  Chemical shift imaging (CSI) is one of the most commonly used localized 
spectroscopy techniques. CSI is also known as 2D spectroscopy MRI. The PSD of 2D CSI is 
shown on Figure 1-5. The main difference between 2D CSI and GRE imaging is the absence 




Figure 1-5. PSD of 2D CSI. 
 
RF pulse, phase and frequency encoded gradients are applied in order to localize voxels in-
plane. The FID is acquired, and the NMR spectrum is assigned for the localized voxel. 
  The main advantage of CSI over 2D GRE imaging is its superior sensitivity. In 
addition, because of the lack of a frequency encode gradient, the spectrum of the signal and 
the chemical shift information are preserved during CSI. Moreover, it is easier to detect the 
metabolites of drugs and to study drug metabolism in an organ with CSI. However, CSI 
images are slower to generate than GRE images of comparable resolution. Therefore, a 
separate CSI image can be reconstructed for each spectral component. A time series of CSI 
images allows one to evaluate the signal time evolution of different spectral peaks in different 
regions of the sample. This information reflects the metabolism of the compound which 
produces the tracked MRS spectral peak.  
1.5 Arterial Spin Labeling MRI. Perfusion imaging 
  Arterial Spin Labeling (ASL) is an MRI technique used to assess the blood-flow and 
perfusion of internal organs95–98. This approach relies on the difference between spin-lattice 
relaxation of blood protons and tissue protons97. ASL requires acquisition of two MRI images 
subsequently. The first MRI image of the region of interest (ROI) is acquired using a 
conventional imaging pulse sequence without any modifications (“untagged” image). In order 
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to acquire the second image, the initial selective 180O RF inversion pulse is applied prior the 
excitation pulse. This inversion pulse is applied to a slice located closer to the heart compared 
to the ROI (a tagging region). The applied 180O pulse inverts longitudinal magnetization of 
the arterial blood in the tagging region. Due to the spin-lattice relaxation, the longitudinal 
magnetization of the tagged blood grows back with time while flowing in the arteries to the 
ROI. The time delay between the inversion pulse and excitation pulse is chosen specifically 
to allow the tagged blood to reach the ROI and to allow the longitudinal magnetization of the 
arterial blood to reach approximately zero value. If the time delay is picked with high 
accuracy, the second “tagged” image of the ROI will have no contribution from the arterial 
blood washed-into the ROI. Therefore, the image acquired after subtraction of the “tagged” 
image from the “untagged” image represents the blood distribution throughout the ROI. 
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 [1-48] 
where M is the measured difference in the MRI image signals, ibR is the relaxation rate of 
blood, itR is relaxation rate of tissue,  is labeling efficiency,  is arterial transit time, w is 
post labeling delay time, and 0bM is an equilibrium longitudinal magnetization of the arterial 
blood. Eq. [1-48] illustrates one of the main issues associated with ASL perfusion images, 
which is the high number of parameters that influence the resulting image.  
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  Usually, the signal difference M is only a few percent for perfusion imaging100. 
Therefore, ASL perfusion imaging requires high NSA to ensure sufficient SNR of the 
resulting image. Moreover, there are technical difficulties associated with achieving complete 
saturation of the arterial blood in the “tagging” area. Although significant improvement in 
perfusion imaging was achieved with the invention of pseudo-continuous ASL (pCASL)101–
103, there are still multiple challenges in the field of ASL perfusion imaging, such as 
sensitivity to a motion104, the lack of consensus about tagging strategy103, complexity of the 
ASL perfusion model103, and high sensitivity to the proton signal variation in the background 
signal105. 
 
1.6 Blood Oxygenation Level Dependent MRI. Hemodynamic Response 
and functional imaging of the human brain 
 
   Conventional proton MRI is sensitive to changes in blood oxygenation. This 
phenomenon is called Blood Oxygenation Level Dependence (BOLD)106,107 and has been 
used to detect human brain function108 as well as renal oxygenation109.  
   BOLD imaging relies on the magnetic differences between oxyhemoglobin and 
deoxyhemoglobin107. Paramagnetic deoxyhemoglobin facilitates dephasing of the 
surrounding water spins and decreasing the apparent spin-spin relaxation. By contrast, the 
diamagnetic oxyhemoglobin does not affect the surrounding spins and causes no difference in 
T2
* relaxation. Therefore, the MRI signal near the blood vessel with highly oxygenated blood 
will be higher compared to the same vessel containing deoxygenated blood. The main 
application of the BOLD effect is functional magnetic resonance imaging (fMRI) of the 
human brain. fMRI detects the change in the local blood-flow oxygenation in the activation 
regions of the human brain as well as changes in cerebral blood flow caused either by brain 
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stimulation (conventional fMRI) or by the high regional oxygen metabolism (resting state 
fMRI).  
   If the brain region is stimulated, it will require a higher amount of oxygen in order to 
function properly. Therefore, the local blood flow will be increased in the area nearby the 
stimulated brain region, yielding a higher concentration of oxyhemoglobin compared to the 
resting state.  This phenomenon of local blood flow increase as a result of regional brain 
activation is known as hemodynamic response (HDR)110. HDR is also known to be well 
correlated with neuronal activity and detection of the HDR during the brain stimulation can 
indicate directly the brain areas involved in the processing of the stimulus110. Therefore, the 
main aim of the fMRI is detection and localization of hemodynamic response.  
   In order to detect HDR, BOLD imaging is conducted. Taking into account the small 
difference in MRI signal caused by oxygenation change, conventional BOLD fMRI requires 
enormously high NSA. Furthermore, to validate the regional signal pile-up, BOLD fMRI 
requires calculation of statistical significance for the detected signal change. Only areas in 
which p value was estimated to be lower than the significance threshold will be considered as 
“activated”. Therefore, conventional BOLD fMRI utilizes the acquisition of a high number of 
scans during the resting state, with subsequent multiple image acquisitions during the 
stimulation. Although there are multiple different experimental designs for BOLD fMRI, the 
most commonly used are block design, event-related design, and mixed task design111. The 
schematic representation of these task designs is shown in Figure 1-6. During the block 
design the subject is exposed to a continuous stimulation during some amount of time 
(usually about 20-30 s) followed by the resting state for the same period of time. The 
stimulus/rest block is alternated during the fMRI study. Event-related task design can be 
described as repeated single activation events over the fMRI scan separated by the relatively 




Figure 1–6. The most commonly used task designs for fMRI: A) block design; B) event-related design; 
C) mixed design. Red letters S demonstrate activation of stimulus, whereas black letters R represent 
resting state. 
 
The BOLD signal change during an fMRI experiment is given by the Davis model112: 
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 [1-49] 
where 2CMRO is the cerebral metabolic rate of oxygen consumption, CBF is the cerebral 
blood flow,  and  are numerical parameters, and M is a calibration parameter. Index 0 
represents the parameters of the resting state. It can be seen that both blood flow and 
oxygenation contribute to the formation of the BOLD fMRI signal. The percent signal change 
due to the BOLD effect strongly depends on the external field strength112 and does not exceed 
10%113.  
  It was observed that percent change of cerebral oxygen consumption is substantially 
lower compared to percent CBF change in response to brain stimulation113–115. Taking into 
account the low overall BOLD signal, the direct detection of HDR using ASL blood flow 
imaging was developed as another fMRI approach112,116,117. This ASL approach of fMRI 
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demonstrated up to 50% signal enhancement116, completely outperforming BOLD fMRI. 
Other advantages of the ASL-based fMRI approach are low sensitivity to susceptibility 
effect, possibility of signal quantification, and more accurate signal localization117. However, 
ASL-based fMRI has lower temporal resolution and lower image SNR compared to BOLD 
fMRI117. Therefore, ASL-based fMRI demonstrates better results with event-related task 
design.   
  Currently, BOLD fMRI is the commonly used fMRI technique since it is easy to 
implement on any MRI scanner without substantial RF and gradient pulse programming. 
 
1.7 Hyperpolarized Noble Gas MRI 
 
  Conventional MRI utilizes NMR signals from thermally polarized nuclei. Thermally 
polarized nuclei have an extremely low value of polarization (~10-5 for protons in the body). 
Therefore, in order to achieve a signal level high enough to conduct MRI imaging, the 
imaged nuclei must have higher gyromagnetic ratio and high natural abundance. 
Furthermore, the concentration of signal nuclei in the sample must be sufficient. In order to 
increase the MRI signal even further, the population of polarized nuclei must somehow be 
increased beyond that at thermal equilibrium. This metastable state with high nuclear spin 
polarization is called the hyperpolarized (HP) state. The use of HP nuclei in MRI was first 
demonstrated by Albert et. al. in 1994118. 
  In order to facilitate the discussion of the HP MRI imaging techniques developed in 
this thesis, the basic concepts of HP MRI are described in this section. There are two different 
techniques to create the HP state: spin exchange optical pumping (SEOP), metastable 
exchange optical pumping, and dynamic nuclear polarization (DNP). DNP is mainly used to 
produce HP 13C and metastable exchange optical pumping is used to produce HP 3He, 
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therefore, will not be discussed here since this thesis is focused on use of HP 129Xe gas. For 
more details regarding the basic principles of HP noble gas MRI, the readers are referred to 
“Hyperpolarized and Inert Gas MRI: From Technology To Application In Research And 
Medicine” by Albert and Hane119. 
1.7.1 Spin Exchange Optical Pumping 
   SEOP is the approach which allows production of HP noble gases with a sufficiently 
high level of polarization. HP metastable state is produced due to angular moment transition 
from circularly polarized laser light to alkali metal (AM) vapor with subsequent transfer of 
polarization from AM electrons to the noble gas nuclei. Although any AM can be used for 
SEOP, the most commonly used metal is rubidium (Rb) due to its low melting point, high 
spin-exchange cross-section for AM/noble gas, and the availability of high-power and 
narrow-bandwidth lasers tunable to the 1D transition.  
  The initial stage of the SEOP is polarization of the s-shell of AM. The scheme of this 
process is shown in Figure 1-7 for the case of Rb vapor. The noble gas, rubidium vapor, and 
quenching gas (usually nitrogen) are confined in the polarization chamber. The circularly 
polarized light induces transition from the ground state 1/25S to the first excited state 1/25P  of 
the AM. The selection rule indicating the possible electron transition is 1m =  , where m is 
magnetic quantum number. The left circularly polarized light induces transition from spin-
down ground substate into spin-up excited substate (shown by red arrow in Figure 1-7). The 
right circular polarization will induce transition from the spin-up ground substate into spin-
down excited substate. Once the electron is excited, it will relax back to the initial ground 
state. Collisions with noble gas atoms rapidly equalize the population of the 1/25P sublevels. 
Once excited, the electrons of the AM relax back to the ground state. This transition occurs in 
accordance with the selection rule mentioned above.  
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 However, to facilitate the polarization of AM vapor, the polarization chamber contains 
quenching 2N gas. Due to collisions with 2N molecules, the electron transition between the  
 
 
Figure 1-7. The transition scheme of Rb electrons during the SEOP process. The red arrow indicates 
the transition caused by circularly polarized light absorption. 
 
excited state and the ground state of the same spin orientation are induced. The processes 
described above continue until all of the AM vapor becomes spin-polarized. 
  Once the AM vapor is spin-polarized, the angular momentum can be transferred from 
the s-shell electrons of AM to the noble gas nuclei through hyperfine Fermi interaction. The 
spin-exchange process can occur either through two-body or three-body non-elastic 
collisions. Two body collision is a dominant process at the higher noble gas pressures (~760 
Torr). The spin exchange in this case happens during collisions between AM atoms and noble 
gas. On the contrary, at low pressures (~10-100 Torr), the dominant mechanism of spin-
exchange appears to be creation of van der Waals molecules from AM and noble gas atoms. 
Although van der Waals molecules are destroyed due to collisions with 2N molecules, their 




  Overall, the probability of successful spin-exchange transfer is low due to often non-
spin-conservative AM/noble gas interaction. Nevertheless, the polarization of AM vapor is 
rapidly restored due to constant irradiation of the chamber with circularly polarized photons. 
AM atoms with recovered spin polarization continue to interact with the remaining non-
polarized noble gas molecules, increasing noble gas nuclear polarization over time.  
1.7.2 Physical properties of HP nuclei. Imaging pulse sequences 
   Since HP is a non thermally-equilibrium state, the nuclear magnetic properties of the 
HP nuclei are dramatically different from those of thermally polarized nuclei.  
   As was discussed in section 1.4, spin-lattice relaxation brings the nuclear 
magnetization to the thermal equilibrium state. Therefore, it causes regrowth of the 
longitudinal magnetization with time. On the contrary, in case of HP nuclei, bringing the 
system to thermal equilibrium means decay of the longitudinal magnetization. The first term 
in Eq. [1-26] becomes dominant ( )( )00M M  due to the large population excess of one of 
the Zeeman levels, and the equation for T1 relaxation can be written as follows: 
 ( ) ( ) 1/0 .t TzM t M e
−
=  [1-50] 
This T1-associated exponential decay of longitudinal magnetization causes inapplicability of 
the conventional MRI imaging pulse sequences for HP imaging case. 
   Generally speaking, there are two approaches to HP imaging. The first is to use low 
FA excitation pulses for each line of k-space. This technique preserves longitudinal 
magnetization for further RF excitation. However, the MRI signal is significantly lower 
compared to the possible signal acquired following 90O FA pulses. Furthermore, the loss of 
magnetization accumulates over the k-space trajectories, resulting in image blurring. In order 
to prevent blurring and image artifacts, variable FA can be used to compensate the signal loss 
between different k-space lines. On the other hand, if the FA is constant, each k-space 
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trajectory can be corrected with respect to the magnetization loss due to the series of flip 
angles. This k-space correction overcomes the blurring issue as well. 
  Another HP image acquisition technique utilizes an initial 90O excitation pulse. Once 
the first k-space trajectory is collected, magnetization is quickly tipped back to the z-axis for 
the next k-space line acquisition. The key advantage of this HP imaging technique is a 
substantial increase in image SNR as compared with low FA imaging. However, the spin-
spin relaxation time of the HP media must be long relative to the acquisition time. This 
imaging approach also extremely sensitive to B1 and B0 inhomogeneities, resulting in image 
artifacts. 
   Due to the non-renewable nature of magnetization in the HP state, there is no need to 
use a long TR for image acquisition. Therefore, HP MRI scans are often fast and time 
efficient.  
1.7.3 HP 129Xe functional imaging of the lungs  
   The first demonstration of HP MRI imaging principles was done using 129Xe gas. 
Over the whole history of HP MRI, 129Xe remains the most popular and commonly used gas 
for preclinical and clinical HP MRI imaging.  
   HP 129Xe is safe for inhalation. Although Xe is a general anesthetic agent, it can be 
safely inhaled if the total concentration of the 129Xe gas in the lung is kept below 50%120. The 
most commonly used breathing protocol for HP 129Xe, is a single breath-hold inhalation of 1L 
of HP 129Xe121–123. This protocol keeps the lung concentration of 129Xe below 50% and has no 
reported serious adverse effects.  
   The overall physical properties of HP 129Xe are summarized in Table 1-2. The natural 
abundance of 129Xe is 26% which is sufficient for human lung imaging. Images acquired after 
breath-hold initiation reveal the lung areas which are well-ventilated. Signal voids are caused 
by ventilation defects and lung obstructions. HP 129Xe ventilation imaging allows calculation 
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of ventilation volume and ventilation defect percentage (1 – ventilation volume) which are 
well-known biomarkers for pulmonary disorders. In addition to ventilation parameters, HP 
129Xe lung imaging is capable of probing  
Table 1-2: Physical properties of HP 129Xe2 
Nuclear spin 1/2 
Gyromagnetic ratio, MHz∙rad/T -74.519 
Natural abundance, % 26 
Chemical shift range, ppm 250 
T1 in lungs, s 20 
Ostwald solubility, L 0.17 
Self-diffusion coefficient, cm2s-1 0.061 
 
the lung microstructure and alveolar size. This is typically done by HP 129Xe DWI124,125. The 
resulting ADC of inhaled 129Xe is used for regional calculation of the alveolar size, providing 
researchers with an important metric for lung microstructure. 
  Due to relatively high Oswald solubility, HP 129Xe freely dissolves in blood126. In 
addition, because of its large electron cloud, HP 129Xe is highly sensitive to the change in 
physical and chemical environment, resulting in distinct chemical shift due to dissolution in 
blood and different tissues. Therefore, HP 129Xe has been used to study gas transfer in the 
lungs. There are two different techniques capable of gas transfer assessment that are 
commonly used: chemical shift saturation transfer (CSSR), and xenon transfer contrast 
(XTC). 
   CSSR is an MRS technique which measures the average gas transfer time of HP 129Xe 
from the gas phase through lung parenchyma into the alveolar blood127. The narrow BW 90O 
saturation pulse is applied to the dissolved HP 129Xe at the beginning of the CSSR sequence. 
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Since the HP state is non-recoverable, this initial RF pulse destroys the NMR signal from the 
dissolved 129Xe. Due to the constant exchange between the gas phase and the dissolved phase, 
the signal of dissolved HP 129Xe will recover after some time. This recovery time is measured 
and frequently called the transfer time. The measured HP 129Xe transfer time was shown to 
correlate with lung parenchyma thickness128 and was proposed as a biomarker for asthma128, 
chronic obstructive pulmonary disorder129, and radiation induced lung injury130.  
   XTC images gas transfer through the acquisition of numerous time-resolved 
depolarization maps of the HP 129Xe in the gas phase131,132. In the XTC experiment, multiple 
depolarization pulses are applied at the Larmor frequency of HP 129Xe dissolved in blood and 
lung tissue. Similar to the CSSR experiment, some amount of HP nuclei from the gas phase 
will replace depolarized nuclei due to constant exchange between the gas phase and dissolved 
phase. This replacement results in gas phase signal depletion which is mapped during the 
XTC imaging. The produced depolarization map allows localization of lung tissue 
heterogeneity. 
1.7.4 HP 129Xe imaging of the brain 
   Functional imaging of the lungs remains the main practical application of HP 129Xe 
MRI. However, once HP 129Xe is dissolved in blood, it distributes to the highly perfused 
organs such as brain and kidneys. Therefore, it is possible to use HP 129Xe as an inhalation 
contrast agent for imaging of highly perfused organs since HP 129Xe has sufficiently long T1 
relaxation time in blood133,134. Furthermore, HP 129Xe can be used for perfusion imaging as 
well... Since concentration of HP 129Xe dissolved in blood is low135,136, isotopically enriched 
HP 129Xe is commonly used for imaging of the dissolved phase122,123,137,138 in order to 
increase the image SNR significantly.  
   HP 129Xe imaging of the human brain has been developed extensively over the past 
twenty years. Starting from the pioneering MRS experiments in animals139–143, five spectral 
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peaks were observed in the HP 129Xe brain spectrum. Further spectroscopy studies in 
humans137 confirmed findings of the animal experiments. The strongest peak at +198 ppm 
with respect to the gas phase was associated with grey matter. The spectral peak at +192 ppm 
originates from white matter. A peak at +188 ppm was associated with soft muscle tissue 
whereas the signal at +200 ppm originated from plasma. The last peak at +217 ppm was 
associated with HP 129Xe dissolved in red blood cells (RBC). 
   The first HP 129Xe image of the human brain was obtained in 2015.144 Subsequently, 
the correlation between cerebral perfusion and HP 129Xe signal in the brain was realized. The 
possibility of using HP 129Xe brain imaging for cerebral perfusion imaging was demonstrated 
in healthy volunteers145 and stroke patients121. However, HP 129Xe imaging without 
appropriate image post-processing resulted only in qualitative agreement between the HP 
129Xe brain image and CBF images acquired with ASL.  
   In order to conduct quantitative perfusion imaging of the human brain, the dynamic 
acquisition of multiple images over the breath hold is required. This dynamic imaging 
approach was successfully implemented for imaging patients with Alzheimer’s disease122 for 
which the HP 129Xe wash-out time was proposed as a potential biomarker. In addition, the 
dynamic imaging of HP 129Xe dissolved in the brain was successfully used for quantitative 
imaging of the cerebral perfusion in healthy volunteers123.  
   Most recently, HP 129Xe brain imaging was shown to be capable of detecting the 
hemodynamic response to visual and motor stimuli and, thus, of conducting fMRI studies123. 
Despite the lower spatial resolution of HP 129Xe fMRI compared to proton fMRI, the image 
acquisition time is substantially shorter making HP 129Xe fMRI the fastest fMRI technique. 
   Despite numerous advances made in HP 129Xe brain imaging, the technique remains 
extremely challenging. The major issue is associated with the low concentration (~1 µM135) 
of HP 129Xe in the brain. In addition, this concentration tends to vary between subjects due to 
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interpersonal pulmonological differences. This raises a question about the repeatability of HP 
129Xe brain imaging and makes image comparison between subjects difficult.   
1.8 Thesis Outline 
  Chapter 1 has described the background of multinuclear MRI, its advantages over 
conventional proton MRI, and potential challenges. A brief overview of functional 
multinuclear MRI application was presented. The basic principles of MRI physics were 
presented as well as basic principles of HP MRI, followed by an overview of HP 129Xe MRI 
for lung and brain imaging. 
   Chapters 2 through 4 are briefly described below; these chapters demonstrate work 
completed in partial fulfillment of the requirements for the degree of Doctor of Philosophy in 
Chemistry and Materials Science at Lakehead University.  
   Chapter 2 describes the application of 19F CSI for the cancer resistivity detection to 5-
fluorouracil chemotherapy. In this work, 2D 19F CSI imaging was performed in groups of 
mice bearing two different types of human colorectal adenocarcinoma. By measuring the 
chemotherapy retention in the tumor, the resistive type of adenocarcinoma was successfully 
identified. This work was published in Nature Scientific Reports (peer-reviewed journal) in 
2019.86  
   Chapter 3 discusses the potential of octafluorocyclobutane as an inhalation agent for 
19F lung MRI. In this work, octafluorocyclobutane was theoretically and experimentally 
compared to the most commonly used inert fluorinated inhalation agent – perfluoropropane. 
This study was conducted in a healthy rat cohort. Octafluorocyclobutane ventilation images 
demonstrated superior SNR compared to perfluoropropane images for both single breath-hold 
and continuous breathing protocols. This work was published in Magnetic Resonance in 
Medicine (peer-reviewed journal) in 2020.72 
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   Chapter 4 describes the novel HP 129Xe Time-of-Flight pulse sequence which is 
capable of measuring perfusion quantitatively. This imaging technique was tested on 
phantoms followed by imaging of healthy volunteers’ brains. The mathematical model and 
the algorithm for image processing was developed as well. As an example of the application 
of the HP 129Xe Time-of-Flight technique, the hemodynamic response to visual and motor 
stimuli was detected and correlated to proton BOLD fMRI images. All HP 129Xe HDR maps 
correlated well with conventional fMRI images. This work was published in Diagnostics 
(peer-reviewed journal) in 2020.123 
  Chapter 5 provides a brief overall summary of my thesis work and discusses possible 
future advances and research directions.  
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Chapter 2: Detection of colorectal adenocarcinoma resistivity to 
5-fluorouracil using fluorine-19 MRI 
 
This topic has been elaborated in the following publication: Shepelytskyi Y., Fox MS., 
Davenport K., Li T., Albert MS., Davenport E “In-vivo Retention of 5-Fluorouracil Using 
19F Magnetic Resonance Chemical Shift Imaging in Colorectal Cancer in a Murine 
Model” published in Scientific Reports, volume 9, Article number: 13244 (2019). The 
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Colorectal cancer is the third leading cause of cancer death worldwide. 5-Fluorouracil (5-FU) 
is one of the most commonly used chemotherapies for treatment of solid tumours, including 
colorectal cancer. The efficacy of treatment is dependent on tumour type and can only be 
determined six weeks after beginning chemotherapy, with only 40–50% of patients 
responding positively to the 5-FU therapy. In this paper, we demonstrate the potential of 
using Magnetic Resonance (MR) Chemical Shift Imaging (CSI) for in-vivo monitoring of 5-
FU tumor-retention in two different colorectal tumour types (HT-29 & H-508). Time curves 
for 5-FU signals from the liver and bladder were also acquired. We observed significant 
differences (p < 0.01) in 5-FU signal time dependencies for the HT-29 and H-508 tumours. 
Retention of 5-FU occurred in the H-508 tumour, whereas the HT-29 tumour is not expected 
to retain 5FU due to the observation of the negative b time constant indicating a decline in 
5FU within the tumour. This study successfully demonstrates that CSI may be a useful tool 
for early identification of 5-FU responsive tumours based on observed tumour retention of 
the 5-FU. 
Introduction 
Colorectal cancer is the third most common cause of cancer death worldwide 
according to the World Healthcare Organization1 and is the second most commonly 
diagnosed cancer in Canada according to the Canadian Cancer Society2. Colorectal cancer is 
responsible for approximately 14% of new cancer cases and 12% of cancer deaths in 
Canada3. According to Canadian Cancer Statistics (2016), 7% of men and 6% of women are 
expected to develop colorectal cancer during their lifetimes2. Moreover, an increasing 
incidence of colorectal cancer among young adults in Canada has been observed4.  
5-Fluorouracil (5-FU) is one of the most widely used cytotoxic chemotherapies for 
treatment of a variety of solid tumours, including colorectal and breast cancer5–9. However, 
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the treatment response rate (percentage of patients whose tumour shrinks or disappeared after 
treatment) for 5-FU based chemotherapy are relatively low5,10. Biochemical modulation of 5-
FU has increased response rates up to 40–50%5,11,12, while the influence on overall survival 
has been limited8. The improvement in overall survival was observed when 5-FU was 
modulated with irinotecan13,14. The current colorectal cancer mortality rates reflect – at least 
in part – resistance of individual tumours to 5-FU treatment. It has been clinically 
demonstrated that the “trapping phenomenon” (the half-life of drug in the tumour is longer 
than 20 minutes) correlates with the clinical effectiveness of 5-FU chemotherapy15. Thus, a 
method to detect the responsiveness of a tumor to 5-FU in the earliest stages of treatment 
(i.e., sooner than six weeks) may enable effective targeting of 5-FU therapy to responsive 
tumours and also may prevent unnecessary exposure to cytotoxic chemotherapy in patients 
with 5-FU resistant tumours.  
It is hoped that early identification of 5-FU resistant colorectal tumours will enable 
oncologists to choose treatment strategies more likely to improve patient survival and 
minimize unnecessary morbidity. 
 Several previous studies using MRI were conducted using Diffusion-Weighted 
Imaging (DWI) for early detection of the treatment response in patients with colorectal 
cancer16–18. It was found that the increase in Apparent Diffusion Coefficient (ADC) of tissue 
water within the tumour was significantly higher in responders compared to non-
responders16. Marugami et al. was able to distinguish responders from non-responders 9 days 
after the initiation of chemotherapy based on the ADC changes in liver methastasis17. 
However, patients already received two infusions of 5-FU. Similar result was obtained by 
Lavdas et al.18. Although these results can be considered as an early detection of the tumour 
response, there are several limitations associated with DWI. Due to power requirements, 
hardware limitations and other external factors DWI accuracy is limited and the image 
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quality is low19. Furthermore, DWI image are often susceptible to various artifacts like 
ghosting, blurring, ringing, distortions etc19,20. 
 It is hypothesized that the early monitoring of 5-FU retention at the site of colorectal 
tumours can indicate the tumour responsiveness to 5-FU chemotherapy. 5-FU metabolizes 
into fluorinated nucleotides (Fnuc) and α-fluoro-β-alanine (Fbal) that each display a different 
chemical shift (i.e., 5-FU and its metabolites have different resonant frequencies in the 19F 
magnetic resonance (MR) spectrum21–28. All of them can be visualized using Magnetic 
Resonance Imaging (MRI). Chemical-Shift Selective images of 5-FU and its metabolites 
have been previously acquired in a rat model22–25 and in a mouse model26–28. The high natural 
abundance (approximately 100%) and large gyromagnetic ratio of Fluorine-19 (19F) lead to a 
strong observed signal of 5-FU. 19F MRI is a non-invasive and non-ionizing imaging 
technique. Another significant benefit of using 19F MRI is the absence of fluorinated 
compounds in the human body, thus there is no natural background signal. These characteris- 
tics together, make 19F MRI a promising method for monitoring 5-FU retention immediately 
following a single chemotherapy treatment. This would be a significant improvement to the 
current method for evaluating the efficacy of chemotherapy based on the observation of 
reduced tumour size after prescribed chemotherapy treatment. 
 Chemical Shift Imaging (CSI) is an extension of MR spectroscopy (MRS), allowing 
metabolite information to be measured. This technique has already been used for imaging the 
small intestines of mice with orally administrated 5-FU28. Also, CSI has been used for 
imaging the liver of patients with colorectal cancer and breast cancer29 and to study the 
metabolism of 5-FU in liver metastasis30,31. Although the metabolism of 5-FU was studied 
within tumours27,28,32 and liver29, the CSI imaging technique of 5-FU was not used for tumour 




 The purpose of this study was to determine if there were observable differences 
between the signal to noise ratio (SNR) from colorectal tumours that are insensitive (HT-
29)33,34 and sensitive (H-508)35 to 5-FU administration as a function of time. Significant 
differences between SNR values allow us to infer the potential utility of 19F CSI to detect 





 A total of 23 mice were imaged: 9 mice with the HT-29 tumour (non-responder), 9 
mice with the H-508 tumour (responder), and 5 mice with both tumour types. For each 
animal, the SNR from the tumour, bladder and liver voxels were calculated.  
 The obtained values were used for plotting the SNR time-dependence curves to detect 
the presence or absence of 5-FU retention in given tumours. If any organ or tumor was bigger 
than a single voxel, a mean value of the SNR from all voxels containing the organ or tumor 
was calculated and used in the subsequent analysis.  
 Figure 2-1 represents the 19F CSI images acquired at 7.5(a & b) and 40 minutes (c & 
d) after bolus injection, superimposed on the 1H scans for two representative mice. HT-29 
tumour cells were injected into mouse 1 (Fig. 2-1a,c), whereas mouse 2 (Fig. 2-1b,d) received 
H-508 tumour cells. 19F SNR values higher than 50 (attributed to bladder uptake) were 
thresholded to create necessary contrast in tumour voxels between the images acquired at 7.5 





Figure 2 – 1. 19F CSI superimposed onto 1H localizer images. (a,c) represent 19F CSI of the HT-29 (non 
5-FU responsive) tumour mouse. (b,d) correspond to CSI of the H-508 (5-FU responsive) tumour 
mouse. The colour bar represents 5-FU SNR. (a,b) were acquired at 7.5 minutes after bolus injection, 
whereas (c,d) were acquired at 40 minutes after 5-FU injection. At 40 minutes, the signal was 
concentrated in the H-508 tumor, bladder and kidneys. Notice that the SNR from the H-508 tumour in 
(d) increased by 36% after 40 minutes. 
 
  The SNR of the HT-29 tumor was 9 at 7.5 minutes after injection (Fig. 2-1a). The 
SNR from the H-508 tumour voxel was 22.6 at the same time (Fig. 2-1b). After 40 minutes, 
the SNR value from the H-29 tumour decreased slightly and was equal to 7.2 (Fig. 2-1c), 
whereas the H-508 tumour SNR increased by 36% and was equal to 30.8 (Fig. 2-1d). 
The liver SNR from the H-508 mouse decreased gradually from 17.8 to 8.3 
throughout time. However, the SNR from the liver voxels in mouse 1 was equal to 
approximately 11 at 7.5 minutes after bolus and 10 at 40 minutes after injection. Bladder 
SNR was equal to 24.7 and 25.7 for mouse 1 and mouse 2 respectively at 7.5 minutes after 
injection. At the end of the time period, bladder SNR was equal to 86 for the HT-29 mouse 





Figure 2 – 2. Time course of 5-FU SNR from the tumour, liver, and bladder voxels for representative 
mouse with a HT-29 tumour (a) and mouse with a H-508 tumour. (b) The HT-29 (non-responder) SNR 
steady decreased throughout the time interval (a), whereas SNR from the H-508 (tumor responder) 
voxel increased gradually. (b) The pink curve represents the exponential fit (Eq. [2-1]) of the tumour 
SNR curves. 
 
Figure 2-2 illustrates the 5-FU SNR time dependences in the tumour, liver, and 
bladder voxels from representative images of HT–29 (Fig. 2-2a) and H-508 (Fig. 2-2b) 
tumours shown in Fig. 1-9. The HT-29 tumour SNR decreased steadily throughout time. On 
the contrary, the SNR from the H-508 tumour voxel grew gradually. The bladder signal 
steadily increased over time. The liver signal from the HT-29 mouse slightly oscillated 
around the mean value, which was equal to 10. However, the SNR of the liver voxels of 
mouse 2 significantly grew from 2.5 to 7.5 minutes after bolus. After 7.5 minutes, the SNR 
declined gradually. 
 Figure 2-3 shows the 19F CSIs of mouse 3 superimposed on proton scans. This mouse 
had both tumour types. The HT-29 tumour was injected into the left flank of the animal 
whereas the H-508 colorectal adenocarcinoma was injected into the right flank. There are no 
liver voxels on these CSI images. 19F SNR values higher than 50 were thresholded to visually 
create necessary contrast in tumor voxels between the figures acquired at different times. 




Figure 2-3. 19F CSI superimposed onto 1H localizer images. Images (a,b) show a representative mouse 
with both HT-29 (non 5-FU responsive, injected in the left flank of the animal) and H-508 (5-FU 
responsive, right flank) tumours at 5 and 70 minutes after 5-FU injection, respectively. The colour bar 
represents 5-FU SNR. After 70 minutes, high 5-FU signal was acquired from the H-508 tumour, kidneys 
and bladder. (b) Note that the H-508 SNR after 70 minutes was approximately two times higher than at 
the beginning of study, whereas HT-29 SNR dropped more than 3 times (b) comparing to the initial 
value (a). 
 
Figure 2-3a,b were acquired at 5 and 70 minutes after bolus injection. The SNRs from 
the HT-29 and the H-508 voxels at 5 minutes after injection were 26.6 and 12.8 respectively 
(Fig. 2-3a). After 70 minutes, the SNR from the HT-29 tumor was 3.4-fold lower than the 
initial value and equal to 7.9. However, SNR from the H-508 tumour was equal to 31.1 at 70 
minutes after bolus. The SNR from the bladder voxels in Fig. 2-3a was approximately 44,  
whereas after 70 minutes the SNR was 81.4, which is almost 2 times higher than the signal 
obtained at 5 minutes after the bolus (Fig. 2-3b).  
 Figure 2-4 shows the time curve evolution of SNR from both tumour types and the 
bladder. The HT-29 tumour signal increased during the first 10 minutes after 5-FU injection. 
Nevertheless, SNR decreased steadily throughout time from 10 to 70 minutes after bolus. On 
the contrary, the signal from the H-508 tumor increased gradually up to 22.5 minutes. The 
bladder signal grew steadily throughout the first 30 minutes and then leveled. The difference 
between the HT-29 and the H-508 SNR time curves was statistically significant according to 
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Wilcoxon signed rank test (p < 0.01). After 30 minutes, bladder time dependency plateaued at 
a value of 83 with minor oscillations.  
 All tumour SNR time curves were fitted using an exponential function with two fitting 
parameters – amplitude “a” and time constant “b” (Eq. [2-1]). One HT-29 tumour curve was 
excluded from analysis due to poor good- ness of fit. In one of the animals which was 
injected with both tumour types, the H-508 tumour was not detected. Therefore, just the HT-
29 tumour curve was measured. Table 2-1 represents the values of the time constants “b” 
obtained for the HT-29 and H-508 singe-tumour mice. The values shown in Table 2-1 has 
been used for statistical evaluation of the obtained results. If the mean value of the observed 
time constants is positive and significantly different from a zero value, the tumour can 
successfully retain 5-FU. 
 
 
Figure 2-4. 5-FU SNR time curves from the HT-29 (left tumour) (Fig. 2-3a), the H-508 (right tumour) 
(Fig. 2-3b) and the bladder of representative mouse which had both tumor types. The pink and green 
curves correspond to the exponential fit of the HT-29 and H-508 SNR values respectively. Notice that 
the HT-29 (non 5-FU responsive tumour) SNR dropped gradually during time period from 10 to 70 
minutes after bolus. On the contrary, the H-508 (5-FU responsive tumour) SNR grew steadily 
throughout the first 22.5 minutes. 
64 
 
Table 2-1. The time constants “b” (min−1) obtained from the exponential fit of HT-29 and 
H-508 SNR time curves of single-tumour mice. 
 HT-29 H-508 
1 -0.014 ± 0.003 0.013 ± 0.006 
2 -0.006 ± 0.005 0.028 ± 0.007 
3 0.007 ± 0.004 0.013 ± 0.003 
4 -0.011 ± 0.0004 0.044 ± 0.008 
5 0.0003 ± 0.001 0.005 ± 0.006 
6 0.009 ± 0.002 0.034 ± 0.008 
7 -0.007 ± 0.003 0.011 ± 0.009 
8 -0.006 ± 0.003 -0.002 ± 0.001 
9 -0.012 ± 0.002 0.017 ± 0.003 
Mean ± SD -0.004 ± 0.008 0.018 ± 0.015 
The mean value + /− one standard deviation of the time constants for the HT-29 
tumour in single-tumor mice was equal to -0.004 ± 0.008 min−1. On the contrary, the mean 
time constant “b” for the H-508 tumour was equal to 0.018 ± 0.015 min−1. The results are 
significantly different according to two-sample unpaired t-test (p < 0.01). Furthermore, 
according to one-sample t-test, the mean value for the H-508 tumour is significantly greater 
than 0 (p < 0.01). Figure 2-5 shows a box chart analysis of time constants from both tumour 
types with a significant difference of p < 0.01 between the tumour types. Based on this 







Figure 2–5. Box chart of the time constant for the HT-29 (non 5-FU responder) and the H-508 (5-FU 
trapper) tumours of single-tumour mice group. Mean value of the time constant for the HT-29 tumour 
was equal to −4 × 10−3 min−1, however for the H-508 tumour mean time constant was equal to 18 × 
10−3min−1. 
 
 The mean values of the time constant “b” for the H-508 and HT-29 tumors of dual-
tumour cohort were equal to 0.006 ± 0.009 min−1 and −0.001 ± 0.008 min−1 respectively. The 
difference in mean values was not statistically significant (p > 0.01). However, the Wilcoxon 
test showed that SNR curves of two different tumours from the dual-tumour animals were 




  The results of this study illustrate the feasibility of detecting a 5-FU retention in 
different types of colorectal cancers using 19F CSI imaging. Time curves of the 5-FU signal 
acquired following bolus injection can reveal the difference in uptake of 5-FU in different 
tumour types. Time curves of the 5-FU signal acquired right after a bolus injection of the 
chemotherapy drug had different dynamics for two different types of human colon 
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adenocarcinoma. Therefore, detection of tumour resistance to chemotherapy based on a 5-FU 
retention is possible approximately one hour after bolus injection.  
  5-FU SNR changes with time were found to be significantly different (p < 0.01) for 
the HT-29 and H-508 tumour types. Increasing 5-FU SNR throughout time is characteristic of 
the H-508 tumour, whereas the HT-29 tumour type SNR shows a tendency to decrease or to 
remain constant. This result was obtained for the single-tumor mice and it was statistically 
significant (p < 0.01). A significant difference between time constant “b” for the dual-tumour 
animals was not observed (p > 0.01). It could be due to a small number of samples (n = 5). 
These results are consistent with the literature which shows that the HT-29 tumor 
demonstrates resistivity to 5-FU therapy while the H-508 tumor can be treated using             
5-FU33–35. 
  We did not observe 5-FU “trapping phenomenon” as described by Presant during the 
studies timeline from both tumour types. For the H-508 type, the signal did not reach steady-
state, so we were not able to estimate the half-life time for the 5-FU in the tumor. However, 
the retention of 5-FU in H-508 tumour was observed over the studied time course. The HT-29 
tumour is not expected to retain 5-FU due to the observation of the negative b time constant 
indicating a decline in 5-FU within the tumour. 
 5-FU SNR within the bladder increased steadily from injection time to 70 minutes 
after treatment. Nearly all of the bladder 5-FU SNR was observed to be stronger than the 
tumour and liver SNRs. This finding could be due to catabolism of 5-FU in the liver. The 
limiting factor of 5-FU metabolism in the liver could be attributable to the activity of the 
enzyme dihydrouracil dehydrogenase5,24. Indeed, Fig. 2-2 illustrates the decay of the liver 
SNR with time. This time course corroborates the results, obtained in the rat model32. The 




  Unfortunately, we were not able to observe the signals of 5-FU metabolites such as 
Fbal and Fnuc. 5-FU catabolizes into Fnuc in the tumour5,27,32, whereas Fbal can be found in 
the liver, tumor, and kidneys5,23,27,32. According to Otake (2011), Fnuc signal was observed 1 
hour after bolus and Fbal signal was detected 10 minutes after injection32. In that study, the 
authors used a 7.0T animal MRI system. The absence of a 19F signal from the fluorinated 
metabolites could be due to the small concentration of these metabolites in the organs and 
tumours. Our study time interval was likely too short to allow for a high concentration of 
catabolites to be produced. Future imaging of the metabolites Fbal and Fnuc requires further 
parameter optimization due to the low SNR of these metabolites even 40 minutes after bolus. 
Additionally, to improve the sensitivity of the RF coil, a phased array coil could be used for 
better coupling with 19F nuclei in the tumor and organs. 
 Overall, our studies demonstrate that 19F CSI imaging can be used to detect retention 
of 5-Fluorouracil in a murine model of colorectal cancer. This technique may extend 
prediction of patient tumour resistivity to 5-FU chemotherapy based on the pharmacokinetics 
of 5-FU at an early treatment stage, yielding an improvement in personalized cancer therapy. 
Implementing innovative imaging strategies that identify patients who respond to 5-FU 
would increase the efficacy of the treatment by allowing targeted matching of patients and 
chemotherapy agents in the neoadjuvant setting. This MRI-based technique could be readily 
implemented clinically as a means of non-invasively monitoring early response to 5-FU 
chemotherapy. Identifying resistant tumours early in cancer treatment will enable patients 
unlikely to respond to 5-FU therapy to rapidly alter treatment plans. The use of 19F CSI to 
triage patients into different chemotherapy regimens could be a significant innovation and 





Materials and Methods 
 
Cell lines and culture conditions 
 
 All human colon adenocarcinoma cell lines, media, sera, and culture reagents were 
obtained from ATCC (Burlington, ON, Canada), Life Technologies (Burlington, Ontario, 
Canada), Becton Dickinson (St. Laurent, Quebec, Canada) or Sigma (St. Louis, MO). HT-29 
cells were grown in McCoy’s 5 A medium and NCI-H508 were grown in RPMI-1640 
medium, with both cell lines supplemented with 10% FBS, 100U/ml Penicillin, 100 µg/ml 
streptomycin, and 2 mM glutamine. Cells were grown to 50–75% confluency in T-75 flasks 
prior to injection into animals. 
 
In Vivo cell implantation and tumour growth in immunodeficient mice 
 
This study was approved by Lakehead University Animal Care Committee, and all 
procedures were done in compliance with the regulations of the Canadian Counsel on Animal 
Care (CCAC). HT-29 and NCI-H508 cells were grown in T-75 flasks between 60–80% 
confluency. Cells were trypsinized with 0.25% (w/v) Trypsin −0.53 mM EDTA solution, 
resuspended in appropriate medium, and counted. 1×106 human colon adenocarcinoma cells 
were mixed with a 1:1 ratio cold Matrigel (Corning Matrigel, Fisher Scientific) for each 100 
µl bolus injection into 36–40 day-old male (Nu/Nu) nude mice. Briefly, nude mice were 
anesthetized using 3% isoflurane and injected with 100ul of a 1:1 cold Matrigel 
solution of either 1×106 HT-29 or NCI-H508 cells using a BD Eclipse 27 G × 1/2 needle. 
Mice were injected under the skin in the left (HT-29) or right flank (NCI-H508), weighed, 
labelled by ear piercing, and immediately returned to cages. Mock mice were injected 
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similarly with 100 µl of a 1:1 ratio of appropriate cold medium and Matrigel while control 
mice received no injection. The H-508 tumour grew more slowly than HT-29. Therefore, the 
dual-tumour mice were injected with HT-29 tumor 5 days post HT-508 cells injection. A total 
of 23 mice were injected with either HT-29 cells (9 mice), H – 508 cells (9 mice) or both 
adenocarcinoma types (5 mice). All animal imaging was performed 12–16 days post injection 
or when a caliper measurement of the volume of the tumours did not exceed either 450 ± 75 
mm3 for animals with single tumours or 600 ± 75 mm3 in total for the dual-tumour mice. The 




Prior to the MRI scanning procedure, all animals were anesthetized using 5% 
isoflurane oxygen mixture and anesthesia was maintained at 2% with oxygen during all 
subsequent experiments. Mice were catheterized using a MTV-01 tail-vein catheter (SAI 
Instruments). All animals received a slow bolus injection of 300 µl 5-FU (50 mg/ml) over the 
course of 2 minutes inside the magnet bore. During each MRI acquisition, animals were kept 
at 37 C° with a temperature-controlled water-filled blanket (T/Pump, Gaymar).  
MRI was performed using a clinical Philips 3.0 T Achieva whole-body scanner, 
equipped with a custom-built dual-tuned 1H/19F quadrature birdcage coil. Proton localization 
was performed using a multi-slice T1-weighted Turbo Spin Echo (TSE) pulse sequence with 
a Field of View (FOV) of 75×75 mm2, TR/TE = 2000/55.19 ms, slice thickness of 2 mm and 
Number of Signal Averages (NSA) = 3. Acquisition matrix size was equal to 256×256 which 
corresponds to the in-plane resolution of 0.29 mm. The total number of slices was equal to 16 




After the bolus injection, 19F CSI images were acquired for up to 70 minutes with a 
time step of 2 minutes and 30 seconds. Mice that had one tumour type were studied using CSI 
with 8×5 resolution, FOV of 20×50 mm2 and NSA = 3, whereas mice with both tumour types 
were studied using 3×5 matrix, FOV equal to 31 × 18.6 mm2 and NSA = 9. All CSI images 
were acquired using spectral bandwidth of 32 kHz (266 ppm at 3.0 T) and TR/ TE = 
5000/4.27 ms. The data sampling number was 1024, yielding a spectral resolution of 0.26 
ppm.  
Images were analyzed using a custom imaging processing program written in 




All SNR time curves were fitted by the exponential function: 
 ,btSNR ae=  [2-1] 
where amplitude a and time constant b were fitting parameters. The time constant determines 
signal dynamics. If the time constant is positive, the signal will grow with time, conversely 
when it is negative, signal will decrease. Thus, time constant can be used as an indicator of 5-
FU kinetics. A two-sample t-test was applied for b time constant to analyze the statistical 
significance of the fitted results for the single tumour animals. A one-sample t-test was 
applied to the b time constant of each group of single tumour animals to evaluate if the mean 
b value of each group was significantly different from 0. A Wilcoxon signed rank test has 
been used to evaluate the difference between SNR time curves obtained from different 
tumors in dual-tumor animals. OriginPro 2016 was used to conduct statistical analysis 
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Chapter 3: Performance improvement of 19F lung MRI using 
octafluorocyclobutane 
This topic has been elaborated in the following publication: Shepelytskyi Y., Li T., Grynko 
V., Newman C., Hane FT., Albert MS “Evaluation of fluorine-19 magnetic resonance 
imaging of the lungs using octafluorocyclobutane in a rat model” published in 
Magnetic Resonance in Medicine, volume 85, issue 2, pages: 987-994 (2021). The 
publication text is listed below.  
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Purpose: To test octafluorocyclobutane (OFCB) as an inhalation contrast agent for fluorine-
19 MRI of the lung, and to compare the image quality of OFCB scans with perfluoropropane 
(PFP) scans  
Theory and Methods: After normalizing for the number of signal averages, a theoretical 
comparison between the OFCB signal-to-noise ratio (SNR) and PFP SNR predicted the 
average SNR advantage of 90% using OFCB during gradient echo imaging. The OFCB 
relaxometry was conducted using single-voxel spectroscopy and spin-echo imaging. A 
comparison of OFCB and PFP SNRs was performed in vitro and in vivo. Five healthy 
Sprague-Dawley rats were imaged during single breath-hold and continuous breathing using 
a Philips Achieva 3.0T MRI scanner (Philips, Andover, MA). The scan time was constant for 
both gases. Statistical comparison between PFP and OFCB scans was conducted using a 
paired t test and by calculating the Bayes factor. 
Results: Spin-lattice (T1) and effective spin-spin (T2*) relaxation time constants of the pure 
OFCB gas were determined as 28.5 ± 1.2 ms and 10.5 ± 1.8 ms, respectively. Mixing with 
21% of oxygen decreased T1 by 30% and T2* by 20%. The OFCB in vivo images showed 
73% higher normalized SNR on average compared with images acquired using PFP. The 
statistical significance was shown by both paired t test and calculated Bayes factors. The 
experimental results agree with theoretical calculations within the error of the relaxation 
parameter measurements.  
Conclusion: The quality of the lung images acquired using OFCB was significantly better 
compared with PFP scans. The OFCB images had higher a SNR and were artifact-free. 
 
Keywords: 





MRI of inhaled inert fluorinated gases demonstrated promising results as a novel lung 
imaging modality.1-3 A variety of studies using sulfur hexafluoride (SF6),4-6 perfluoroethane 
(C2F6),7-9 and perfluoropropane (PFP-C3F8)2,5,10-12 demonstrated the feasibility of fluorine-19 
(19F) MRI of the lung for diagnostics and the study of many lung disorders. Fluorinated gases 
can be mixed with oxygen (O2) and used for continuous-breathing imaging, which allows for 
dynamic scanning and the study of dynamic lung physiology, including the fractional 
ventilation measurement study.4,13 The short T1 relaxation times of fluorinated gases allows a 
high number of signal averages, resulting in a sufficient image signal-to-noise ratio (SNR). 
Other advantages of 19F lung MRI are that it has a high natural abundance (~100%) and a 
large gyromagnetic ratio, which maximizes the 19F MRI signal.9 
Despite the advantages associated with 19F MRI, the SNR of acquired images is lower 
compared with another lung imaging modality: hyperpolarized noble gas MRI.1,3 This 
attribute results from the natural Boltzmann distribution of the spins in the Zeeman energy 
states for fluorinated gases, as opposed to hyperpolarized gases. Multiple studies have re- 
searched ways of improving the quality of ventilation images acquired with fluorinated 
gases.2,12,14-16 The main factors that affect SNR are the number of equivalent 19F atoms and 
the relaxation time of the fluorinated gas. Therefore, it is feasible to explore other fluorinated 
gases that can enhance the SNR associated with 19F MRI. Octafluorocyclobutane (C4F8 
[OFCB]) belongs to the family of inert fluorinated gases, contains eight chemically 
equivalent fluorine atoms per molecule (which is a greater number of equivalent 19F atoms 
compared to other fluorinated gases), and has a longer spin-spin relaxation time. OFCB is a 
commercially available gas, with a similar cost as PFP (13.8$ per liter). All these factors 
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make OFCB a promising candidate for 19F lung MRI. Although OFCB has not been clinically 
approved for human inhalation, it has no adverse effects based on inhalation.17 
Previous reports by Wolf et al.18 and Friedrich et al.19 used OFCB for the 
visualization of inert gas washout during high-frequency oscillatory ventilation. Recently, the 
first spin-echo images of human lungs using OFCB were acquired at 0.5T.20 
The goal of this work was to compare OFCB with PFP and to determine the feasibility 
of using OFCB as a fluorinated gas for 19F lung MRI by comparing its SNR to the SNR of 
PFP scans. In this work, we demonstrate that OFCB has a higher SNR than PFP for both MR 
spectroscopy and imaging. In addition, we measured all relaxation parameters of the pure gas 
and the gas premixed with 20% O2 and studied the influence of the unequal number of 
averages on the SNR comparison. 
 
2. Theory 
To calculate the theoretical signal for the steady-state condition, the following 
























where α is the flip angle (FA). Because the T1 time of the OFCB–O2 mixture is 
approximately 70% longer compared with PFP–O2 (Table 3-1), to make a proper estimation 
of their SNR performance, the number of signal averages (NSA) of OFCB–O2 scans should 
be 70% less compared with PFP–O2 NSA (to keep scan time the same for both 
measurements). Using the measured relaxation parameters in vivo (Table 3-1) and NSA for a 
single breath-hold protocol, the ratio of OFCB SNR normalized on NSA to PFP normalized 




Figure 3-1. Theoretical dependence of in vivo octafluorocyclobutane–oxygen (OFCB-O2) to 
perfluoropropane–oxygen (PFP–O2) signal-to-noise ratio (SNR) as a function of pulse repetition times 
(TRs). The SNR values were normalized on the number of signal averages (NSA) used for the animal 
scans (NSAOFCB = 16, NSAPFP = 24). The normalized SNR of PFP gas can excite the normalized SNR 
of OFCB only if TROFCB <7 ms. However, this value is impractical for a 70°-Ernst angle; therefore, it 
will never be used for the real scans. The white dot represents the experimental results. It can be seen 
that the experimental result nicely agrees with theoretical calculations. 
 
FA (Figure 3-1). Using Equation [3-1], the theoretical SNR advantage of using OFCB was 
calculated for three types of scan parameters. For a single breath-hold experiment, OFCB 
normalized SNR should be 86% higher compared with PFP. For continuous breathing using a 
70° FA, the normalized SNR advantage of OFCB should be equal to 98%, whereas for a full-




3.1. General Information 
This study was divided into two parts: (1) A phantom study to measure the relaxation 
parameters of pure gases and O2 mixtures. A SNR comparison of OFCB and PFP gradient 
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echo (GRE) images was also conducted. (2) A SNR comparison in vivo by acquiring 
ventilation images of healthy rat lungs. For this study, a clinical Philips Achieva 3T MRI 
scanner (Philips, Andover, MA) was equipped with a custom-built quadrature birdcage coil 
tuned to the Larmor frequency of fluorine (120.15 MHz). Four phantoms, consisting of a 
syringe containing 8 mL of one of the gases, OFCB (99.9999%; Advanced Specialty Gases, 
Reno, NV), pure PFP (>99.99%; Air Liquide, Paris, France), OFCB breathing mixture (79% 
OFCB mixed with 21% O2), and the medical-grade PFP (79% PFP mixed with 21% O2) were 
used.  
 
3.2. Phantom Study 
MR spectra of the gas phantoms were acquired using the following parameters: TR/TE = 750 
ms/0.14 ms, bandwidth (BW) = 32 kHz, sampling number = 2048, and FA = 90°. The 
spectral peaks were fitted to the Lorentzian peak shape and T2* was extracted from full-width 
half-maximum (FWHM) of the fitted peak using equation T2* =1/πFWHM. To measure the 
spin-lattice (T1) relaxation time constant, a series of inversion recovery (IR) spectra was 
acquired. Pure gases were studied using the following inversion times (TIs): TImin = 4 ms, 
TImax = 91 ms, and ΔTI = 3 ms. The O2 mixtures were studied using TImin = 4 ms, TImax = 28 
ms, and ΔTI = 1 ms. Other spectroscopy parameters were the same as outlined above.  
Following the spectroscopy study, the direct comparison of the two axial 19F GRE images of 
OFCB phantoms and PFP phantoms were acquired. The following GRE imaging parameters 
were used for the imaging of pure gases: field of view (FOV) = 100 × 100 mm2, 64 × 64 
matrix, TR/TE = 200 ms/1 ms, and Cartesian sampling. To image the breathing mixture 
phantoms, the following repetition times were used: TRPFP-O2 = 63 ms, TROFCB-O2 = 100 ms, 
and FA = 90°. All other parameters were kept the same for imaging the pure gases. The SNR 
was calculated as the peak intensity to the standard deviation (SD) of the noise region ratio. 
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Table 3-1. Measured T1 and T2* relaxation times and gradient echo image SNR of the studied gases 
 T1(ms) T2*(ms) 
GRE SNR (experimental 
values) 
GRE SNR (normalized 
for NSA) 
OFCB 28.5 ± 1.2 10.5±1.8 45.52 45.52 
PFP 18.6 ± 0.4 6.26±0.27 30.26 30.26 
OFCB-O2 20.4 ± 0.21 8.6 ± 0.5 14.52 14.52 
PFP-O2 14.98±0.61 5.4 ± 0.3  9.42 9.42 
OFCB-O2 
(in vivo) 
17.77 ± 1.5 3.4 ± 0.4 
9.72 ± 2.1  
(breath-hold) 
14.48 ± 4.51  
(continuous breathing, 70°)  
10.23 ± 0.70 
 (continuous breathing, 90°) 
0.61 ± 0.13 
(breath hold) 
0.1 ± 0.03  
(continuous breathing, 70°) 





12.8 ± 1.1 2.2 ± 0.3 
7.66 ± 2.0  
(breath-hold) 
12.68 ± 4.09  
(continuous breathing, 70°) 
8.81 ± 0.46  
(continuous breathing, 90°) 
0.32 ± 0.08  
(breath hold) 
0.06 ± 0.02  
(continuous breathing, 70°)  
0.21 ± 0.01  
(continuous breathing, 90°) 
 
3.3 Animal study 
 
3.3.1. Animal preparation 
All animal studies were conducted in accordance with the guidelines of the Canadian 
Council on Animal Care and approved by the Lakehead University Animal Care Committee 
(AUP 1463772). Five healthy Sprague-Dawley rats weighing between 300 and 400 g were 
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imaged in this study. The animals were prepared for surgery as described in Chahal et al.21 
Briefly, rats were anesthetized with isoflurane and propofol. A midline incision allowed an 
endotracheal catheter to be placed. The catheter was connected to a custom-built rodent 
ventilator. 
The rat was given a OFCB–O2 breathing mixture (79% of OFCB mixed with 21% O2) 
at 60 breaths per minute with a 4-mL tidal volume. The rat was placed inside the custom-built 
quadrature 19F coil. After the OFCB data acquisition, the ventilator was switched to pure O2 
to remove any OFCB left inside the lungs. Following 5 minutes of O2 ventilation, the 
ventilator was switched to a PFP–O2 breathing mixture. Following the PFP data acquisition, 
the animals were euthanized by barbiturate overdose. 
 
3.3.2. In vivo imaging 
Two different breathing protocols were performed in this study: a single breath-hold 
for 11 seconds, and continuous breathing for 3 minutes and 5 seconds. All lung images were 
acquired using a GRE pulse sequence with a Cartesian readout. All animals were scanned 
during a single breath-hold; however, only three rats were scanned using the continuous 
breathing protocol. During continuous breathing, the two sets of scans were conducted: (1) 
using the Ernst angle condition that is most commonly used in preclinical studies, and (2) 
using the condition of full recovery of longitudinal magnetization for a more accurate 
comparison between two gases at laboratory conditions because this regime is almost 
insensitive to T1 variation of the inhaled gas mixture. 
T1 and T2* relaxation times have been measured in vivo using the same approach from 
the phantom study.  
The 19F lung projection images during single breath-hold were acquired using the 
following parameters: FOV = 100 × 100 mm2, 32 × 32 acquisition matrix, TE = 0.63 ms, FA 
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= 70°, and BW = 436 Hz/pixel. To keep the scan time equal to the breath-hold duration, the 
NSAs were equal to 16 and 24 for OFCB and PFP breathing mixtures, respectively.  
The 19F lung projections for the continuous breathing protocol were acquired either 
using full recovery (FA = 90°) or using the 70° Ernst FA. The following GRE pulse sequence 
parameters were used: FOV = 100 × 100 mm2, 64 × 64 acquisition matrix, TE = 0.95 ms, BW 
= 246 Hz/pixel, and scan time = 185 seconds. The NSAs of 144 and 221 were used for OFCB 
and PFP, respectively, when the 70° FA was used. During the full-recovery scans, the NSA 
for the OFCB scan was equal to 29, whereas the PFP NSA was equal to 41. The following 
TR values were used in this study: TRPFP-O2/ TROFCB-O2 = 12.5 ms/20 ms (FA = 70°) and 
TRPFP-O2/ TROFCB-O2 = 63 ms/100 ms (FA = 90°). No respiratory gating was used. 
 
3.3.3 Data processing 
The spectroscopy data processing, paired t test, and all fitting were calculated using 
OriginPro 2016 software (OriginLab Corp, Northampton, MA). The 19F MR images were 
reconstructed and analyzed using custom MATLAB scripts in MATLAB R2016b 
(MathWorks, Inc, Natick, MA). The image SNR was calculated as the mean signal value in a 
rectangular region of interest in the right lung divided by the SD of noise in a similar region 
of interest in the background. The calculation of the Bayes factor for the statistical analysis 
was conducted using the MATLAB Bayes factor package (v.1.0.0 by Bart Krekelberg). The 
criterion of significance of the results, based on the value of Bayes factor, was used as 
published by Kass and Raftery.22 The theoretical TR versus TE plot was created using 








4.1 The phantom study 
The spin-lattice relaxation time constant (T1) of pure OFCB was measured to be 28.5 
± 1.2 ms (Figure 3-2A). The T1 relaxation time of pure PFP was measured and was equal to 
18.6 ± 0.4 ms, which is similar to values reported in Chang and Conradi.23 The measured T2* 
 relaxation times were equal to 10.5 ± 1.8 ms and 6.26 ± 0.3 ms for OFCB and PFP, 
respectively. 
 Following relaxometry of the pure gases, the relaxation properties of the 20% O2 
mixtures were measured. The T1 relaxation time of the OFCB–O2 mixture was shortened to 
20.4 ± 0.21 ms, and the T1 time of the PFP–O2 mixture was equal to 14.98 ± 0.61 ms. The 
T2* relaxation times were equal to 8.6 ± 0.5 ms and 5.4 ± 0.3 ms for OFCB–O2 and PFP–O2 
mixtures, respectively.  
 Single-voxel (SV) spectroscopy of OFCB, PFP, and their respective O2 mixtures was 
conducted to see the signal difference on the MR spectra. The acquired spectra of the pure 
gases are shown in Figure 3-2A. The single-voxel spectra of the 20% O2 mixtures are 
presented in Figure 3-2C. The SNR values were equal to 628.44, 499.91, 400.44, and 362.10 




Figure 3-2. A representative inversion recovery curve measured for pure OFCB (A). The measured 
spectra of 8 ml of pure PFP (blue) and OFCB (red) (B). Spectra (C) were obtained from 8ml of PFP 
and OFCB breathing mixtures. The horizontal lines represent the maximum value of the corresponding 
MRS peak. 
 
from pure OFCB gas was approximately 1.57 times higher than pure PFP SNR. However, the 
SNR value of the OFCB–O2 spectrum was approximately 38% higher than the PFP–O2 SNR.  
 Because the PFP gas has a shorter T2* relaxation time, the peak appeared broader and 
shorter. The ratio of PFP integral values to the OFCB integral was equal to 0.74 and 0.75 for 
pure gases and O2 mixtures. This result agrees with the theoretical 6:8 ratio predicted from a 
molecular structure of the studied gases. 
GRE imaging was conducted on phantoms to evaluate the SNR performance of OFCB. The 
OFCB images were compared with the image of the main peak of PFP. The SNR of the pure 
PFP phantom image was equal to 30.26, whereas the SNR of the pure OFCB was 
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approximately 50% higher and equal to 45.52. The presence of O2 did not cause any decrease 
for the SNR difference. The SNR of the OFCB–O2 mixture (SNR = 14.22) was 51% higher 
than the SNR of the medical-grade PFP (SNR = 9.42). The measured relaxation times and 
SNR values are summarized in Table 3-1. 
 
4.2. The animal study 
Figure 3-3 shows whole-lung projections in the axial plane acquired during a single 
breath-hold (Figure 3-3A,D) and continuous breathing (Figure 3-3B,C,E,F) from the same 
animal. The first row of images shows the OFCB scans, and the second row shows the PFP 
scans. Figure 3-3B and E were ac- quired using FA = 70°, TRPFP = 13 ms, and TROFCB = 20 
ms. Figure 3-3C and F were acquired using a full recovery of longitudinal magnetization 
condition. 
The normalized SNR value for the NSA of the OFCB single breath-hold image was 
equal to 0.61, which was ap- proximately 85% larger than the normalized SNR image from 
the PFP breathing mixture (SNR = 0.33). The normalized SNR values of images acquired 
using a FA = 70° during 185 seconds of continuous breathing were equal to 0.11 and 0.06 for 
OFCB–O2 and PFP–O2 mixtures, respectively. The SNR advantage of using OFCB was 
calculated to be 83%. Finally, the images acquired using a full-recovery condition during 
continuous breathing had a normalized SNR of 0.37 and 0.22 for OFCB and PFP, 
respectively. 
The T1 values of OFCB–O2 and PFP–O2 mixtures in the animal lungs were equal to 
17.77 ± 1.5 ms and 12.8 ± 1.1 ms. T2* values were equal to 3.4 ms and 2.2 ms for OFCB–O2 




Figure 3-3. In vivo lung ventilation images of a healthy rat acquired in axial projections. The first 
column shows scans acquired during a single breath-hold; the second column corresponds to the scans 
acquired during continuous breathing and using a 70° Ernst angle; the third column contains scans 
obtained during continuous breathing using a 90° flip angle (FA). The signal-to-noise ratio (SNR) of 
the single breath-hold octafluorocyclobutane (OFCB) scan was 21% higher compared with the 
corresponding perfluoropropane (PFP) scan. For continuous breathing, the SNR of the OFCB image 
acquired using the Ernst angle of 70° was 15% stronger. Finally, during continuous breathing scans in 
the full recovery regime, the OFCB SNR exceeded PFP SNR by 17%. The red arrows indicate the 
chemical shift artifact associated with second spectral peak of PFP. 
 
 The nonnormalized SNR values of images acquired using a single breath-hold protocol 
and the SNR values of the scans acquired during the continuous-breathing protocol using a FA 
= 70° and a FA = 90° are shown in Figure 3-4. The SNR of the one axial ventilation image 
acquired during continuous breathing using a 90° FA was not calculated because a ghosting 
artifact was observed on the image. Therefore, this scan was excluded from further statistical 
analysis. The mean normalized and non-normalized SNR values are provided in Table 3-1. 
 
4.3 Statistical analysis 
A paired t test was used to evaluate the SNR difference between the OFCB and PFP 
scans for each image acquisition protocol. The mean values of the nonnormalized SNR values 
for single breath-hold images were equal to 9.12 ± 2.10 and 7.66 ± 2.00 for OFCB and PFP 
90 
 
breathing mixtures, respectively. The OFCB produced significantly a higher SNR (P = .0017), 
which was supported by a Bayes coefficient of 1.4 × 103. 
The mean noncorrected SNR of OFCB images obtained during continuous breathing 
were equal to 14.48 ± 4.51 and 10.23 ± 0.7 using a FA = 70° and a FA = 90°, respectively. The 
average SNR values of PFP images were equal to 12.68 ± 4.09 (FA = 70°) and 8.81 ± 0.46 (FA 
= 90°). OFCB SNR values were significantly higher compared with PFP values (P = .0196 [FA 
= 70°]; P = .038 [FA = 90°]). This significance was supported by values of the Bayes 
coefficient: 331.73 (FA = 70°) and 343.74 (FA = 90°). Both normalized and non-normalized 
SNR values are provided in Table 3-1. 
 
 
Figure 3-4. Non-normalized signal-to-noise ratio (SNR) box charts of scans conducted using the single 
breath-hold protocol, and continuous breathing protocol. The black boxes correspond to 
octafluorocyclobutane (OFCB) scans, and the blue boxes correspond to perfluoropropane (PFP) scans. 
The red squares illustrate the mean SNR of the group. Whiskers illustrate the standard deviation from 
the mean SNR. The SNR values of the OFCB scans were statistically significantly higher compared 
with the PFP scans. The corresponding P values and Bayes factors are shown in the figure legend. The 
wider scatter of SNR values obtained using the Ernst angle condition during continuous breathing can 
be explained by the absence of respiratory gating. The Ernst angle condition strongly depends on the 
T1 relaxation time of the gas in the lungs, and the absence of gating caused a T1 variation because of 






 Inert fluorinated gases can be used as gas contrast agents for MRI of the lungs. 
Currently, PFP is the most common gas agent used in preclinical studies.1,3 The results 
presented above demonstrate the benefits of using OFCB gas as an MRI contrast agent. OFCB 
is inert, which makes it safe for inhalation. The main advantage of OFCB over PFP is the 
presence of eight chemically equivalent nuclei in the molecule. Furthermore, it has a longer 
effective transverse relaxation time constant than the PFP T2* value. These two properties 
cause OFCB SNR to be 1.57 times higher than the PFP SNR. The results comparing GRE SNR 
of PFP and OFCB phantoms showed slightly less SNR differences than spectroscopy. 
However, the SNR of OFCB images was significantly higher than images of PFP phantoms. 
 The measured spin-lattice relaxation parameter of pure OFCB was similar to that 
reported by Friedirich et al.19 Interestingly, the effective spin-spin relaxation time constant was 
approximately half of what was previously published. This shortening of T2* could be 
explained by the effect of a two times stronger external magnetic field compared to what was 
previously used in the literature.19 The obtained PFPs relaxation parameters values were close 
to those published by Chang and Couch.23,24 
 The short T1 relaxation time is an advantage of fluorinated gases, which allows high 
NSA acquisition during a single breath-hold. OFCB has the longer T1 relaxation time com- 
pared with other widely used fluorinated gases. Theoretical calculations of SNR showed that 
OFCB still produces higher SNR even with a smaller amount of averages. Because OFCB 
allows the acquisition of higher SNRs using lower NSA, the specific absorption rate of the 




 OFCB has another practical advantage compared with PFP: The 19F spectrum of OFCB 
contains only one single peak, whereas the PFP spectrum has two peaks. As a result, the signal 
of the second PFP peak should be suppressed to avoid creation of a second lung image, which 
could over- lap with the image of the main peak. OFCB does not have this drawback, which 
makes it more convenient for practical applications.  
 The results of the animal experiments agree with the theoretical calculations (Figure 3-
1). The normalized for NSA OFCB SNR advantage was equal to 90% for a single breath- hold 
(white point on Figure 3-1). The theoretically predicted value of the normalized SNR 
advantage was 86%. There is a slight deviation from the theory for a continuous breathing 
protocol. The normalized SNR advantage of OFCB was calculated to be equal to 98% and 86% 
for the 70° Ernst angle and full longitudinal magnetization conditions, respectively. The 
observed normalized OFCB SNR boosts were equal to 76% for the Ernst-angle condition and 
to 86% for the full longitudinal magnetization recovery condition, which is lower than the 
theoretically predicted value. This can be explained by a slight mismatch between the OFCB 
T1 in vivo and the TR used during the scans and the absence of respiratory gating. The larger 
scatter of SNR values for the Ernst-angle condition (Figure 3-4) is caused by the absence of 
respiratory gating during the scan. Because the 70° Ernst-angle condition depends strongly on 
the T1 of the gas in the lungs, the absence of respiratory gating can potentially cause a variation 
of T1 based on the different concentrations of the fluorinated gases in the lungs. All of the three 
predicted advantages of OFCB (higher SNR, absence of chemical shift artifacts, low specific 
absorption rate) were observed. The SNR of OFCB images was significantly higher even with 
an approximately 65% smaller number of signal averages.  
 In this study, we showed that OFCB is a suitable candidate for 19F MRI of the lungs. 
The image quality of OFCB scans was significantly higher compared with commonly used 
PFP. In addition, OFCB scans are safer in terms of tissue-heating because of a lower specific 
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absorption-rate value compared with PFP. The roughly estimated OFCB-scan specific ab- 
sorption rate is approximately 60% lower compared with PFP scans because of the smaller 
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Chapter 4: Invention of HP 129Xe Time-of-Flight (TOF) perfusion 
imaging. HDR detection using HP 129Xe TOF imaging 
 
4.1. HP 129Xe TOF perfusion imaging methodology 
 
This topic has been elaborated in the following publication: Shepelytskyi Y., Hane FT., 
Grynko V., Li T., Hassan A., and Albert MS. “Hyperpolarized 129Xe Time-of-Flight MR 
Imaging of Perfusion and Brain Function” published in Diagnostics, volume 10, issue 9, 
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Perfusion measurements can provide vital information about the homeostasis of an organ and 
can therefore be used as biomarkers to diagnose a variety of cardiovascular, renal, and 
neurological diseases. Currently, the most common techniques to measure perfusion are 15O 
positron emission tomography (PET), xenon-enhanced computed tomography (CT), single 
photon emission computed tomography (SPECT), dynamic contrast enhanced (DCE) MRI, 
and arterial spin labeling (ASL) MRI. Here, we show how regional perfusion can be 
quantitively measured with magnetic resonance imaging (MRI) using time-resolved 
depolarization of hyperpolarized (HP) xenon-129 (129Xe), and the application of this 
approach to detect changes in cerebral blood flow (CBF) due to a hemodynamic response in 
response to brain stimuli. The investigated HP 129Xe Time-of-Flight (TOF) technique 
produced perfusion images with an average signal-to-noise ratio (SNR) of 10.35. 
Furthermore, to our knowledge, the first hemodynamic response (HDR) map was acquired in 
healthy volunteers using the HP 129Xe TOF imaging. Responses to visual and motor stimuli 
were observed. The acquired HP TOF HDR maps correlated well with traditional proton 
blood oxygenation level-dependent functional MRI. Overall, this study expands the field of 




Perfusion measurements can provide vital information about the homeostasis of an organ [1] 
and can therefore be used as biomarkers to diagnose cardiovascular [2,3], renal [4], and 
neurological [5–7] diseases. Currently, the most commonly used techniques to measure 
perfusion are 15O positron emission tomography (PET) [8–10], xenon-enhanced computed 
tomography (CT) [11,12], single photon emission computed tomography (SPECT) [3,8,13], 
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and arterial spin labeling (ASL) magnetic resonance imaging (MRI) [1,14–18]. In addition, 
dynamic susceptibility contrast (DSC) and dynamic contrast enhanced (DCE) MRI are 
frequently used for perfusion imaging [19–21]. Although these techniques are well-
established, each has some serious drawbacks. CT requires high-dose ionizing radiation, PET 
and SPECT rely on injection of radioactive contrast agents and the acquired PET images are 
of low resolution, and the signal-to-noise ratio (SNR) and contrast of ASL images is low. 
DSC and DCE MRI require injection of contrast agents, most of which contain gadolinium, 
which was recently associated with a certain amount of toxicity [22,23]. In addition, the most 
commonly used gadolinium-based contrast agents are uncapable of crossing the blood–brain 
barrier [24–26], which makes cerebral perfusion imaging with these agents more challenging. 
 Hyperpolarized (HP) xenon-129 (129Xe) MRI is a powerful MRI approach used 
mainly for lung imaging and for the study of lung disorders [27,28]. A hyperpolarized (HP) 
metastable state is produced by spin exchange optical pumping [29–31], and is characterized 
by up to 105 larger longitudinal magnetization compared to thermal polarization [27]. 
Therefore, the magnetic resonance signal of HP nuclei can be up to 105 times stronger than at 
thermal equilibrium. Due to the ability of HP 129Xe to dissolve in blood and travel to highly 
perfused organs, HP 129Xe MRI was recently used to study the brain [6,32–34] and kidneys 
[35]. The last achievements in the field of HP 129Xe MRI allowed the investigation of 
cerebral perfusion changes associated with Alzheimer’s disease [34] and stroke [6]. 
 Since HP 129Xe dissolves in the blood [36] and has extreme sensitivity to chemical 
environments [27], it can be used as a contrast agent to study blood flow and conduct 
perfusion measurements in tissues. Since the HP state is a nonequilibrium, metastable state, 
the longitudinal magnetization is not restored by spin-lattice relaxation once a radiofrequency 
(RF) pulse irradiates the nuclei. After irradiation of a volume element containing HP 129Xe 
dissolved in tissue or blood with a 90O RF pulse, the HP state is completely destroyed and the 
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dissolved HP 129Xe does not produce any significant amount of signal. If there is continuous 
flow into the volume of dissolved 129Xe, and if the MR measurement is conducted following 
a prescribed time delay (time-of-flight (TOF) time), the MR signal is determined mainly by 
the amount of 129Xe washed into the selected volume. We hypothesize that it is possible to 
measure the blood flow and tissue perfusion quantitatively by creating a dynamic imaging 
technique which measures the 129Xe signal evolution with change in TOF. The proposed 
perfusion imaging technique has the potential to open a new pathway for imaging and 
diagnostics of perfusion-related diseases. 
 In this proof-of-concept study, we develop a novel HP 129Xe time-of-flight perfusion 
imaging pulse sequence and evaluate the performance of this technique in vitro and in vivo. 
The first quantitative HP cerebral perfusion images were acquired using the proposed 
technique in healthy volunteers. Furthermore, the HP 129Xe TOF technique was used for 
hemodynamic response detection and was corroborated by conventional proton (1H) blood 
oxygenation level-dependent (BOLD) fMRI. 
 
2.Materials and Methods 
2.1 Pulse Sequence Design 
The Chemical Shift Saturation Recovery (CSSR) pulse sequence is typically used to 
study the time course of hyperpolarized (HP) 129Xe gas exchange in the lungs [37,38]. We 
modified the CSSR sequence for cerebral perfusion imaging using HP 129Xe to create the 
129Xe TOF used in this study (Figure 4-1). The first 90O block pulse has a time duration of 
0.5 ms, which yields a bandwidth (BW) of 2 kHz (56.5 ppm). This pulse is broad enough to 
saturate the HP 129Xe in all brain tissues and the Xe dissolved in blood. After termination of 
the saturation pulse, the unsaturated 129Xe from the lungs flows into the brain during time τ. 
The image pulse sequence is then initiated. Here, the broad-band excitation pulse of spredrex 
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shape was used for imaging. The image was acquired using a Gradient Echo (GRE) pulse 
sequence with a Cartesian read-out. The TOF pulse sequence was repeated three times with 
different recovery times τ (Figure 4-1). To detect hemodynamic response to a visual 
stimulus, we used the following delay times: τ0 = 1 s, τ1 = 6.5 s, τ2 = 8 s. To detect 
hemodynamic response to a motor task, the TOF delays were equal to 2.5 s, 6.8 s, and 7.1 s. 
 
 
Figure 4-1. 129Xe time-of-flight (TOF) perfusion imaging pulse sequence diagram. The 90O pulse with 
narrow bandwidth (in pink) is applied first. After the recovery time delay, τ (the purple arrow), the 
imaging pulse sequence is initiated. The excitation pulse is represented by the blue rectangle. This pulse 
sequence is repeated n times. Index i corresponds to the delay time with an index number i. 
 
2.2. In Vitro Flow Measurements 
 The flow phantom used in this study is shown in Figure 4-2a. The 3.175 mm tube was 
connected to the syringe pump (Kent Scientific Co, Torrington, CT, USA). A 30 mL syringe 
was filled with saline and loaded into the pump. One liter of natural abundant 129Xe (~26%) 
was polarized up to 52% using the Xemed xenon polarizer and dispensed into a TedLar bag. 
A TedLar bag and a saline tube were connected to the membrane contactor (3M Liqui-Cel 
MM-0.5 × 1 Series) to mix HP Xe with saline. The outlet of the membrane contactor was 
connected to the 3.175 mm tube and the end of the tube was placed into the custom-built 
quadrature coil tuned to the Xe resonance frequency at 3T (35.33 MHz). A saline flow rate 
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was set to 5 mL/min, 6 mL/min, 7 mL/min, and 10 mL/min. The 129Xe TOF GRE imaging 
was conducted using 20 TOF recovery times that varied from 200 ms to 2000 ms,with a step 
of 100ms. The following parameters were used for imaging: TR/TE=104.16ms/1.22ms, FA = 
12.5O, FOV = 100 × 100 mm2. 
 
 
Figure 4-2. In vitro phantom design and obtained time-of-flight (TOF) 129Xe curves with Pearson’s 
correlation coefficient. (a) Schematic diagram of the flow phantom used in this study. A syringe pump 
provided four different flow rates, i.e., 5 mL/min, 6 mL/min, 7 mL/min, and 10 mL/ min. (b) 129Xe TOF 
recovery curves were measured using the TOF imaging approach. A difference in flow rate of 1 mL/min 
created well-detected differences in the TOF curves. A quasilinear region was observed between 200 
ms and 700 ms. A nonlinear recovery appeared for longer recovery times, followed by a steady state. 
(c) Pearson’s linear correlation between the flow rate and the slopes of the TOF curves was calculated 
at the quasilinear region. A strong positive correlation (r ≈ 0.988) was observed, indicating the potential 






2.3 In Vivo Cerebral Perfusion Measurements in Healthy Volunteers  
 
This research study was approved (Jan. 28, 2019) by the research ethics boards (REB) 
at Lakehead University (LU) and the Thunder Bay Regional Health Sciences Centre 
(TBRHSC) (REB file number RP-307) and conducted in accordance with the Tri-Council 
Policy Statement-2 (TCPS-2). Nine healthy volunteers between the ages of 21 and 77 were 
recruited from the community for this study. All participants signed an informed consent 
form. All participants were cognitively normal and consented to the data obtained from them 
being disseminated in this report. 
 
2.3.1. 1H Magnetic Resonance Imaging  
 Participants were placed into a dual tuned 1H/129Xe head coil in a Philips Achieva 3T 
clinical MRI scanner. T2-weighted 1H MRI were acquired using a turbo-spin echo (TSE) 
sequence with a Cartesian readout. The high-resolution anatomical proton images were 
acquired in axial and sagittal views. The sagittal images were acquired using a field-of-view 
equal to 250 × 250 × 46 mm3 and a voxel size of 0.98 × 1.04 × 6 mm3. The repetition time 
was set to 3 s and the echo time was equal to 80 s. The flip angle of excitation 
radiofrequency pulse was equal to 90O. Five slices were acquired, separated by 6 mm gaps. 
The axial scans were acquired using similar parameters. The only difference was in voxel 
size, which was equal to 0.98 × 0.99 × 6 mm3 in the axial scans. 
 
2.3.2 129Xe Perfusion Mapping Using Time of Flight (TOF)  
 Enriched 129Xe (83%) was polarized to ~50% using a Xemed xenon polarizer and 
dispensed into 1 L Tedlar bags. The participant breathed in the gas and held their breath for 
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20 s. The dynamic 129Xe TOF imaging pulse sequence with a Cartesian gradient echo readout 
was initiated simultaneously with a breath-hold. Three dynamic projection brain images were 
acquired during the breath-hold. The TOF recovery delays were equal to 2.5 s, 6.7 s, and 7.1 
s. The field of view of gradient echo pulse sequence parameters was equal to 250 × 250 mm2 
and the acquisition matrix was set to 20 × 20. The excitation pulse flip angle was set to 20O. 
The repetition time was equal to 4 ms, the echo time was equal to 0.71 ms, and the 
bandwidth per pixel was 382 Hz. 
 To conduct hemodynamic response mapping, each participant was given two Xe MRI 
scans, one while staring at a gray screen (baseline) and another while exposed to an external 
stimulus, such as a flashing visual pattern (the visual stimulus used in this study can be 
downloaded from the link presented in the Supplementary Material S3) or s rapid left fist 
squeeze (motor stimulus). Exposure to the visual stimulus started approximately 7 s prior to 
image acquisition. Immediately prior to image acquisition, the participant inhaled 1 L of the 
HP 129Xe gas and held their breath for a period of 20 s. 
 A dynamic 129Xe TOF imaging pulse sequence with a Cartesian gradient echo readout 
was initiated simultaneously with a breath-hold using the following parameters: FOV = 250 
× 250 mm2, TR/TE = 4 ms/0.71 ms, FA = 20O, BW = 382 Hz, acquisition matrix = 20 × 20. 
Three dynamic projection brain images were acquired during the breath-hold. The TOF 
recovery delays were equal to 2.5 s, 6.7 s, and 7.1 s for axial projections and 1 s, 6.5 s, and 
7.1 s for the sagittal view. 129Xe TOF perfusion-weighted images were acquired in axial view 
with a slice thickness of 70 mm and in sagittal view with a slice thickness of 300 mm. 
 
2.3.3. 129Xe Perfusion Mapping Image Processing  
 Briefly, 129Xe images were zero-padded in k-space to a 32 × 32 matrix and a Fast 
Fourier transform (FFT) was applied to create MR images. SNR maps were created by 
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dividing each pixel by the standard deviation of the noise region. Based on Killian’s model 
of dissolved Xe [18], the mathematical theory was generalized and applied for HP 129Xe 
perfusion mapping (for a detailed explanation, see Supplementary Material S1). Three SNR 
maps created from TOF images and acquired with different recovery times were fitted pixel-
by-pixel using the linear equation of the SNR delay time dependence (see Supplementary 
Material S2), and slope maps were created. The slope maps were further recalculated into 
perfusion maps using the developed model (see Supplementary Material S1). The SNR of the 
perfusion images was calculated as the ratio of the mean pixel intensity value from the brain 
region to the standard deviation of the selected square region from the background. The 
measured SNR values were compared to the average ASL SNR at 3T published in [39] using 
one-sample t-test. Xe hemodynamic response maps were created by subtracting the baseline 
slope map from the task slope map. An Xe functional brain map was overlaid on top of the 
high-resolution, T2-weighted proton image. Additional image processing information can be 
found in the Supplementary Material S4. 
 
2.3.4. BOLD fMRI Image Acquisition  
 Participants were placed into an eight-channel Philips SENSE coil tuned to the 1H 
nucleus. 180 dynamic multi-slice echo-planar imaging (EPI) scans were acquired using the 
following parameters: FOV = 250 × 250 × 119 mm3, acquisition matrix = 64 × 64, voxel size 
= 3.91 × 3.91 × 4 mm3, TR/TE = 2 s/30 ms, FA = 90◦, 24 slices with a 1 mm slice gap. 
Participants were subjected to the stimuli described above for the first 20 s and then a rest 
period for 20 s. Overall, 18 stimulus/rest repetitions were presented during the BOLD fMRI 
scans. For anatomical localization purposes, high-resolution, T2-weighted, axial images were 
acquired using a turbo-spin echo (TSE) pulse sequence using the following parameters: FOV 
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= 250 × 250 × 119 mm3, voxel size = 0.98 × 0.99 × 4 mm3, TR/TE = 3 s/80 ms, FA = 90◦, 24 
slices of 4 mm thickness separated by 1 mm gaps. 
 
2.3.5. BOLD fMRI Image Processing  
 BOLD fMRI and T2-weighted anatomical images were converted from Philips PAR 
into Analyze format, and multivolume images were segmented into multiple 3D hdr files 
using MRIcro 1.40 (by Chris Rorden). The first 20 EPI scans (first complete cycle) were 
discarded to avoid T1 effects. fMRI data were processed using SPM12 [40] software using 
MATLAB R2018b (The Mathworks, Inc, Natick, MA, USA). Following manual alignment 
of the structural T2 image to the average canonical T2 image, the EPI image was manually 
aligned to the processed structural image. Using the SPM12 software, the obtained aligned 
EPI images were realigned and only the mean image was resliced. After slice timing and co-
registration (an estimate), segmentation of the anatomical T2 image was performed and the 
final image was corrected to remove the spatially varying artifact (modulation of the image 
signal intensity). The functional and anatomical images were normalized using a saved 
deformation field with specification of the voxel size. Smoothing of the functional images 
was done with Full Width at Half Maximum (FWHM) set to 6 mm in all directions. The 
positive t-contrast (stimulus > rest) was calculated for the final functional image. The p-value 
was adjusted to 0.05 with a Family-Wise Error (FWE) correction. No masking or 
thresholding were applied during the image processing. Statistical maps were overlaid on 
volume-rendered brain images provided by SPM12. 
 Signal enhancement was estimated using the MarsBar extension for SPM12 (by 
Matthew Brett, available at http://marsbar.sourceforge.net/). The region of interest (ROI) was 
specified for the cluster with the highest intensity from SPM results file. This was viewed 




3.1. In Vitro Evaluation of HP 129Xe TOF Pulse Sequence 
 
 The 129Xe TOF pulse sequence (Figure 4-1) was programmed on a Philips 3.0T 
Achieva MRI scanner and tested using a flow phantom (Figure 4-2a). A previously 
developed model of Xe uptake in the brain [41] was modified to facilitate quantitative 
perfusion measurements using 129Xe TOF imaging. The complete analytical function, which 
describes the signal evolution in a brain voxel (see Supplementary Material S1), is difficult to 
implement practically and, therefore, a simplified model for the 129Xe wash-in phase was 
developed by employing several assumptions. First, 129Xe relaxation in blood [32,41–45] is 
the predominant factor of polarization decay during the wash-in phase. Second, 
the value of the sum of the tissue perfusion-to-partition coefficient ratio plus the relaxivity of 
HP 129Xe in the tissue is small. With these two assumptions, the SNR evolution during the 
TOF imaging sequence can be expressed as a linear function (for the detailed mathematical 
derivation please see Supplementary Information), where the slope of the line is directly 
proportional to the sum of perfusion of all tissues in the voxel. This approach is valid only 
for short recovery times and can be easily used in practice, albeit yielding an underestimation 
of the slope of the TOF recovery curves for longer TOF delay times. 
 The flow rates were set to 5 mL/min, 6 mL/min, 7 mL/min, and 10 mL/min. The 
signal-to-noise ratio (SNR) increased linearly at small recovery times, followed by a 
nonlinear transition (intermediate recovery times) up until saturation (long recovery times) 
(Figure 4-2b). The nonlinear dynamic at intermediate recovery times can be explained by a 
nonlinear 129Xe velocity distribution in saline flow cross-sections. The signal became 
saturated earlier for the fastest flow rate, whereas a slight signal saturation was observed for 
the slowest flow rate. The slopes of the TOF recovery curves were calculated, and a strong 
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Pearson’s correlation (r = 0.988, p < 0.05) between the flow rate and the signal recovery rate 
was observed (Figure 4-2c). A difference of 1 mL/min in flow caused the observed change in 
the recovery rate. 
 
3.2. HP 129Xe TOF Cerebral Perfusion Imaging  
 
 Human imaging experiments were approved by the research ethics boards at 
Lakehead University and the Thunder Bay Regional Health Science Centre and conducted in 
accordance with the Tri-Council Policy Statement 2. All participants signed an informed 
consent form. During human imaging, the changes in the volunteers’ blood oxygen saturation 
levels were within the normal range. All images were acquired during a single breath-hold 
after inhalation of 1 L of HP 129Xe. The obtained images were converted from radiological to 
anatomical views. 
 Figure 4-3a,f demonstrate the high-resolution, T2-weighted proton images which were 
used for brain localization. Figure 4-3b–d show 129Xe TOF images acquired in the axial 
view after TOF of 2.5, 6.5, and 7.1 s. HP 129Xe TOF sagittal images (Figure 4-3g–i) were 
acquired following 1 s, 6.5 s, and 8 s TOF delays. Following pixel-by-pixel calculations of 
the TOF slope, the corresponding 129Xe TOF perfusion-weighted images were reconstructed 
in both the axial and sagittal projections. The average SNR of the reconstructed, perfusion-
weighted images was equal to 11.2 ± 2.9 (in the sagittal projection) and 9.5 ± 2.9 (in the axial 
projection). Using the theoretical calculations shown in the Supplementary Information, the 
slope maps were transformed into net perfusion maps (Figure 4-3e,j). Although the 129Xe 
TOF pulse sequence is similar to the ASL pulse sequence, the manipulation of the 
magnetization is fundamentally different. The contrast of perfusion-weighted ASL images 
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comes from the difference between control and spin-tagged images, whereas the contrast of 
TOF perfusion maps comes directly from the velocity of incoming blood flow. 
 
 
Figure 4-3. Example of perfusion map acquisition. (a,f) High-resolution, T2-weighted 1H scans for 
brain localization. (b–d) Three dynamic HP 129Xe TOF images acquired 2.5 s, 6.8 s, and 7.1 s after the 
application of a depolarization radiofrequency pulse in the axial projection. The image artifact in the 
top left corner in b is from excess gaseous 129Xe at the end of the inhalation tube connected to the TedLar 
bag. The gradual signal-to-noise ratio increase can be observed with increasing wash-in time. The slope 
map was created by a pixel-by-pixel linear fit of the 129Xe brain images. (e) The perfusion map 
(measured in mL of blood per mL of tissue per min) created by the pixel-by-pixel recalculation of the 
TOF slope was used to calculate the sum of the perfusion rates of gray and white matter superimposed 
on top of a high-resolution proton brain image. The calculated values of perfusion agreed with 
previously observed values [41,46]. (g–i) Three dynamic TOF images acquired after 1s, 6.5 s, and 8 s 
TOF in the sagittal view. (j) Perfusion map in the sagittal view. Similar to e, the intensity values were 
the net sum of the white and gray matter perfusion rates. 
 
3.3. HP 129Xe Hemodynamic Response Detection  
 The blood-flow changes due to the hemodynamic response (HDR) to visual and 
motor stimuli (see Supplementary Material S3) were detected using 129Xe TOF perfusion 
imaging. The experimental designs for HP 129Xe TOF and 1H BOLD fMRI are shown in 
Figure 4-4a,c and Figure 4-5a,c. The reconstructed HDR maps nicely correlated with 1H 
BOLD fMRI and demonstrated the activation of the same brain regions. Activation areas 





Figure 4-4. Detection of a hemodynamic response from a colorful visual stimulus using HP 129Xe 
perfusion mapping validated by blood oxygenation level-dependent (BOLD) functional brain MRI 
(fMRI). (a) Experimental design used for hemodynamic response detection. Two separate perfusion 
maps were acquired during the control (gray screen) and visual stimulation. (b) Hemodynamic response 
map created by subtracting the control perfusion map from the stimulated perfusion map and overlaid 
on top of a high-resolution proton scan. Activation of the occipital lobe, superior parietal lobe, and 
frontal gyrus was observed. (c) BOLD fMRI experimental design for validation of the HP 129Xe 
technique. (d) BOLD fMRI 3D activation maps demonstrate a correlation with a 129Xe hemodynamic 
response map. The activated areas are indicated by colored arrows. The matched activated areas on the 
Xe image are indicated with arrows of the corresponding color. 
 
Figure 4-4 illustrates the results obtained after subjecting the volunteer to the colorful 
rotating dotted visual stimulation. HP 129Xe TOF detected activation of the visual cortex 
(occipital lobe), superior parietal lobe, and frontal gyrus (Figure 4-4b). These results 
completely agreed with 1H BOLD fMRI images acquired by 129Xe TOF image (Figure 4-4d). 
 Figure 4-5 illustrated the experimental design (a,c) and obtained 129Xe TOF HDR 
maps (b) and 1H BOLD fMRI images (d) of the representative volunteers subjected to the 





Figure 4-5. Detection of the hemodynamic response to a motor stimulus using HP 129Xe perfusion 
mapping corroborated by blood oxygenation level-dependent (BOLD) functional brain MRI (fMRI). 
(a) Experimental design used for hemodynamic response detection. Two separate perfusion maps were 
acquired during the control (calm rest) and motor stimulation (left fist clenching) stages. (b) 
Hemodynamic response map created by subtracting the control perfusion map from the stimulated 
perfusion map and overlaid on top of the high-resolution proton scan. Activation of the right posterior 
precentral gyrus (i.e., the motor cortex) was observed. (c) BOLD fMRI experimental design for 
validation of the HP 129Xe technique. (d) BOLD fMRI 3D activation maps. Activation was observed 





There is no HP MRI approach currently available which is suitable for quantitative 
perfusion imaging. Recently, HP MRI was used to detect cerebral perfusion changes caused 
by stroke [35] and Alzheimer’s disease [34]. Since HP 129Xe freely dissolves in the blood and 
travels to highly perfused organs, it can be used as a contrast agent for quantitative imaging 
of perfusion and blood flow. Therefore, HP 129Xe TOF blood flow mapping is a possible next 
step in blood flow and perfusion measurement. 
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 Previous works focused on the dynamic acquisition of multiple brain 
projection images during a breath-hold and the following wash-out time of 129Xe from the 
brain [6,33,34]. Acquired images were subsequently averaged [6,33] or postprocessed to 
characterize the wash-out process of 129Xe from the brain [34]. These approaches were 
strongly dependent on variations in the breath-hold period and the individual lung capacities 
of the subjects. There is typically some signal variation in the 129Xe images acquired from the 
same subject from different breath-holds due to individual variation in the amount of inhaled 
gas, the amount of gas actually in the alveolar lung space, and the amount of gas remaining 
in the trachea and larynx. Therefore, a proper comparison of images acquired from different 
breath-holds is challenging and requires proper signal normalization. 
The HP 129Xe TOF technique is the first differential HP MRI technique, to our 
knowledge, that relies on 129Xe signal recovery rate calculation. This imaging approach is 
fundamentally different from all other MRI methods for blood flow mapping and relies on 
the special properties of HP MRI. An initial depolarization radiofrequency pulse applied to 
the imaging region provides the necessary reference for accurate imaging and makes the 
obtained perfusion-weighted images independent of individual lung capacity and breath-hold 
variations. In addition, the HP 129Xe TOF approach allows quantitative perfusion mapping 
using the derived theory (see Supplementary Material S1). 
Although HP 129Xe blood flow mapping is similar to ASL in terms of pulse 
sequences, this technique overcomes the issue of low signal-to-noise ratio, which is typical 
for ASL perfusion images (the mean SNR of the Xe perfusion maps was approximately 
double compared to values acquired for ASL [39] (p < 0.05)) [1,51]. The obtained 129Xe 
perfusion maps (Figure 4-3e,j) looked similar to results previously obtained from healthy 
volunteers acquired using ASL MRI [52]. With the additional separation of the HP 129Xe 
signals originating from various brain tissues from the signal of 129Xe dissolved in blood 
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(either via different phase separation methods or using chemical shift selective imaging), it 
should be possible to quantitively map the perfusion of each tissue in a region of interest. 
Signal separation of the dissolved 129Xe phases may allow the use of an exact mathematical 
solution for perfusion map calculations (see Supplementary Material S1), which would 
eliminate any potential underestimation of perfusion caused by using an approximate linear 
model. 
Recently, multiple advances in ASL perfusion imaging were achieved by developing 
a pseudo-continuous ASL (pCASL), resulting in an SNR increase compared to conventional 
ASL [16–18,53]. pCASL perfusion images have higher spatial resolution compared to the 
present HP 129Xe TOF images, mainly due to their significantly better developed hardware 
(multichannel coils used for parallel imaging during perfusion imaging) and software 
available for conducting proton ASL MRI. By using a parallel imaging approach, 
compressed sensing, non-Cartesian k-space trajectories, and by developing multichannel 
129Xe coils, it should be possible to acquire HP 129Xe perfusion maps with a spatial resolution 
comparable to pCASL resolution and with a significantly higher SNR. 
Although the scan time for acquiring a single brain perfusion map was ~20 s, it could 
be shortened to ~10 s by reducing TOF recovery time delays. The scan time could be 
shortened further for kidney perfusion measurements, since the reasonably high SNR of HP 
129Xe dissolved in the kidneys can be acquired in less than 4 s [35].  
As one practical application, the HP 129Xe perfusion mapping technique could be used 
for functional imaging of the human brain, which would allow direct hemodynamic response 
mapping. HP 129Xe functional brain maps can be acquired significantly faster compared to 
traditional BOLD functional images. In addition, this approach requires less postprocessing 
than the BOLD technique, which makes it less ambiguous in terms of data processing. 
Although BOLD fMRI and HP 129Xe perfusion mapping are two fundamentally different 
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techniques and quantitative comparisons between them are challenging, the estimated percent 
signal enhancement of the functional maps obtained by HP 129Xe perfusion mapping was up 
to two orders of magnitude larger than the BOLD fMRI images. Xenon gas is used in clinics 
as a general inhalation anesthetic with continuous breathing over several minutes at a total 
lung concentration greater than 50% [54]. Previous studies demonstrated an acceptably low 
incidence of adverse effects caused by inhalation of xenon with an overall alveolar 
concentration below 32% [55]. The concentration of inhaled HP 129Xe in our study was 20–
25% (considering a lung volume of 4–5 L), and there were no side effects observed after 
multiple inhalations and breath-holds. 
A major limitation of the approach demonstrated for 129Xe TOF functional imaging is 
the requirement of acquiring projection images instead of multislice images due to the 
limited quantity of HP 129Xe that is transported to the brain. This issue can be overcome by 
using parallel imaging and compressed sensing techniques, which allow for faster acquisition 
with higher SNR per TOF image. Therefore, a larger number of slices can be scanned during 
a single breath-hold. Another limitation of HP 129Xe perfusion mapping, in terms of its 
clinical relevance, is the ability of a participant to hold their breath. Although the short scan 
time required allows perfusion mapping in patients with lung diseases who can only tolerate 
short breath-hold periods, this technique is not possible for participants who cannot hold their 
breath for at least eight seconds. As an alternative, continuous breathing of an HP 129Xe 
mixture with oxygen could be considered. A continuous breathing protocol has so far only 
been utilized for animal lung studies [56,57]. Translation of this breathing protocol to HP 
perfusion imaging might be challenging due to the oxygen-induced T1 shortening of HP 
129Xe and subsequent decrease in the 129Xe MRI signal. On the other hand, this approach 
could allow for multiple signal averaging and expand the application of HP 129Xe TOF 
perfusion imaging. As a particular example, patients who are not able to hold their breath for 
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eight seconds could be scanned using continuous breathing. Moreover, this might allow for 
HP 129Xe perfusion imaging during clinical procedures when patients are under HP 129Xe-
induced anesthesia. Since the 129Xe TOF technique is based on selective depolarization of 
129Xe nuclei, the MRI scanner needs to be properly calibrated, otherwise there will be an 
additional contribution to the signal from partially depolarized nuclei. Another potential 
limitation for some HP perfusion imaging applications is the time needed for 129Xe 
polarization. The polarizer used in this study requires about 15 min to polarize 1 L of 129Xe. 
Therefore, as a diagnostic tool, HP 129Xe TOF might not be suitable for urgent imaging 
purposes. On the other hand, Xe was shown to demonstrate neuroprotective properties [58], 
indicating a potential use of this modality for cerebral perfusion imaging in stroke patients, 
for example. Finally, the other limitations of this technique are the high cost of enriched 
129Xe gas and the polarizer instrument. It should be noted that the use of enriched 129Xe is 
required by an overall low HP 129Xe signal in the brain. With further hardware development, 
the use of naturally abundant 129Xe, which is substantially less expensive, is expected to 
become more feasible. 
Overall, HP 129Xe perfusion mapping is a novel HP MRI method which, we believe, 
could expand future knowledge in the field of perfusion imaging and functional brain 
mapping. It may also be a useful tool for the detection of perfusion changes in different 
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4.2 Theoretical aspect of HP 129Xe perfusion imaging 
 
This topic has been elaborated in supplementary information to the following publication: 
Shepelytskyi Y., Hane FT., Grynko V., Li T., Hassan A., and Albert MS. “Hyperpolarized 
129Xe Time-of-Flight MR Imaging of Perfusion and Brain Function” published in 
Diagnostics, volume 10, issue 9, Article number: 630 (2020). The derivation of theoretical 





Theoretical aspect of HP 129Xe perfusion imaging 
 
Due to the solubility of 129Xe in blood1, the 129Xe travels with the blood stream to the 
organs. Following Kilian’s2 model, the time evolution of the 129Xe concentration within 
tissue obeys the differential equation: 
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where Ci is a HP 129Xe concentration within the tissue i, Fi is a perfusion rate, piB, the partial 
coefficient between the tissue i and blood, T1i spin-lattice relaxation time of HP 129Xe within 
the tissue i. Kilian’s model can be expanded to describe the concentration of HP 129Xe in a 
one image voxel. We consider a case of the brain imaging. We assume that the MRI signal 
caused by HP 129Xe dissolved in white matter (WM), gray matter (GM) and blood. The 
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where T1A is a spin-lattice relaxation time in the lungs; CB, the 129Xe concentration reaching 
the image voxel at time t; tB, the time required for the blood to reach brain; λB, the Oswald 
solubility of 129Xe in blood; T1B, 129Xe relaxation in blood; Q, pulmonary blood flow; VA, 
alveolar volume. The first two equations are inhomogeneous differential equations of the first 
order. These equations can be solved using the Lagrange’s variation of parameters method. 
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The solution of homogeneous differential equation for the 129Xe concentration in white 
matter in which the integration constant was substituted by the time function is: 
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The C0(t) can be determined after substitution of [4.3] into correspondent equation of [4.2]: 
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The integration constant C* can be calculated since we know that there is a time (tB) that 
129Xe needs to reach the brain. This gives the following condition: 
 0( ) 0 ( ) 0.W BC t C t=  =  [4-6] 
Substituting [4.4] into [4.6], the integration constant C* can be obtained. The Xe 
concentration time dependence in WM can be written as follows: 
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Using the same approach, the concentration of Xe in GM can be expressed as follows: 





















The net concentration of Xe in the image voxel can be described by the following equation: 
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Equation [4.10] describes both wash-in and wash-out of HP 129Xe into and out of the voxel. 
To obtain a more accurate blood flow map, equation [4.10] should be corrected with respect 
to receiving bandwidth and used for pixel-by-pixel fit of 129Xe TOF images. However, the 
fitting process becomes ambiguous due to symmetry of equation [4.10]. Indeed, converting 
FG into FW and βG into βW yields to the same function. Therefore, model simplifications are 
needed for data analysis. Considering wash-in phase and assuming that relaxation in blood is 
predominant factor of signal decay, the following simplification can be used: 
 0; 1.te  −→ →  [4-11] 
Second, we consider a small sum of tissue perfusion and relaxivity of 129Xe in tissue: 
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Using assumptions [4.11] and [4.12], the equation [4.10] can be rewritten as: 
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Equation [4.13] is a linear function of time. The signal to noise ratio is proportional to the 
concentration of the nuclei (SNR=const∙CVoxel). Therefore, the signal to noise ratio evolution 
during the 129Xe TOF scans can be written as: 
 ( )( )0 .G W BSNR SNR F F t= + −  [4-14] 
The slope of equation S.14 is a scaled sum of perfusion rates of WM and GM. This equation 
can be used for creation of perfusion-weighted images of the human brain. By using similar 
approach, it is possible to analyse perfusion of any other organ. 
The solution of the Eqn. [4.1] can be written as:  
 
















i B A B
iB i A A
F
C t e e
F Q
C e
















Considering N tissues in voxel, the net 129Xe concentration can be expressed as follows:  






C t C t C t
=
= +  [4-16] 
and the SNR evolution with TOF recovery obeys the following equation: 
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Chapter 5: Conclusion and Future Work 
5.1 Summary 
 
 Due to the increased demands in personalized medicine and improvements in 
functional imaging, multinuclear (or non-proton) MRI is becoming more and more popular. 
This approach utilizes a variety of different exogenous contrast agents containing non-proton 
nuclei which allows detection and visualization of organ function at disease sites. The most 
widely used areas of multinuclear MRI are 19F MRI and HP MRI. Despite numerous 
advantages in the field, multiple challenges remain unresolved.  
 19F MRI has relatively low SNR compared to conventional 1H MRI due to the small 
concentration of injected 19F nuclei. This fact results in typically low resolution of 19F MRI 
images. Nevertheless, 19F MRI of the lungs is capable of producing relatively high-resolution 
images (usually ~ 64x64 pixels) by employing a large number of signal averages (NSA). 
However, this high NSA results in excessive tissue heating due to the large quantity of RF 
pulses. Further SNR improvement is usually gained through implementation of non-
Cartesian k-space sampling, but this results in poor resolution and can potentially cause 
image artifacts. Therefore, increasing the image SNR of 19F images and implementing low-
resolution and low-SNR 19F molecular MRI are immediate needs.  
 This work demonstrated, for the first time, the possibility of low-resolution 19F CSI 
implementation for tumor resistivity detection to 5-FU. The resistivity of HT-29 
adenocarcinoma has been detected approximately one-hour post bolus injection of 5-FU. 
This methodology has potential to improve personalized cancer care significantly since there 
are no other early-stage tumor resistivity detection methods.  
 Furthermore, this work demonstrated the possibility of OFCB use as an inhalation 
contrast agent for 19F lung MRI. Substantial SNR improvement compared to the most 
131 
 
commonly used PFP gas is caused by the presence of eight magnetically equivalent 19F 
nuclei per OFCB molecule. Moreover, OFCB has the longest apparent spin-spin relaxation 
time constant of all fluorinated gases used for lung imaging. These unique physical 
properties of the OFCB gas allowed up to 21% increase in image SNR with 60% less NSA 
compared to PFP. 
 Finally, this work resolves two major issues in HP 129Xe brain imaging: a) the 
qualitative approach of imaging; and b) the sensitivity of HP 129Xe brain imaging to 
pulmonological differences. Currently, imaging of HP 129Xe dissolved in brain tissue 
strongly depends on the amount of HP 129Xe inhaled by the human subject. Indeed, the signal 
of HP 129Xe in the brain is directly proportional to the amount of HP 129Xe dissolved in blood 
and, therefore, it is proportional to the amount of HP 129Xe enclosed in the subject’s lungs. 
Since the breathing capacity of people differs widely, the HP 129Xe image SNR varies 
between subjects. Therefore, it is incredibly hard to compare images acquired from different 
subjects properly. Due to this variability, HP 129Xe brain imaging mostly remained a 
qualitative approach to roughly estimate cerebral perfusion. 
 The HP 129Xe TOF MRI pulse sequence, invented as part of this work, resolves these 
issues associated with HP 129Xe brain imaging. Due to the presence of an initial 
depolarization pulse, HP 129Xe TOF becomes almost insensitive to interpersonal 
pulmonological variations. The initial selective depolarization pulse sets the clear “baseline” 
with respect to which the signal evolution is measured. This technique makes the HP 129Xe 
signal dependent mainly on CBF. Therefore, the demonstrated HP 129Xe TOF pulse sequence 
is capable of quantifying direct blood flow and perfusion. The mathematical theory 
developed in this work enables quantitative perfusion mapping. The first HP 129Xe cerebral 
perfusion image has been obtained from healthy volunteers. 
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 As one particular example of HP 129Xe TOF application, HDR detection was 
performed. The HDR to visual and motor stimuli was localized. HP 129Xe HDR maps 
correlated well with conventional 1H BOLD fMRI. However, the contrast mechanism of HP 
129Xe TOF HDR mapping is fundamentally different from BOLD since HP 129Xe TOF pulse 
sequence quantifies CBF change directly and does not rely on oxygenation differences. 
  
5.2 Future Work 
 
5.2.1. Hardware development  
 
The MRI image SNR strongly depends on the hardware used in experiments. 
Although the SNR of the acquired images was adequate to support the research hypotheses 
and is common for the research field, it limited the spatial resolution of the acquired scans. In 
order to facilitate further technology development and potential clinical translation, the image 
resolution and SNR should be increased substantially.  
One of the main hardware aspects which determines the image SNR is an RF coil. All 
experiments conducted in this work utilized quadrature single-channel volume coils. 
Although quadrature coils provide sufficient SNR once properly calibrated, multichannel 
phased surface coil arrays can further increase the image SNR and decrease scan time. 
Currently, a parallel imaging approach with multichannel coils is well-developed for 
conventional proton MRI. On the other hand, parallel imaging is not so common in the field 
of multinuclear MRI. A four-channel RF receive coil has been developed for HP 129Xe brain 
imaging recently145 and has been used for two HP 129Xe brain studies1,2. Sixteen-channel RF 
receivers are available for human lung imaging3, are not yet commonly used.  
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Development and implementation of the multichannel phased-array receiver coils will 
be beneficial for all future studies based on the results described in this thesis. Utilization of 
the parallel imaging approach will allow a decrease in scan time for 19F CSI and potentially 
increase NSA which will allow detection of 5-FU metabolites in tumor and liver. Decreased 
scan times and higher NSA will have dramatic effect on OFCB lung images due to a high 
OFCB SNR 4. Finally, implementation of parallel imaging for dissolved phase HP 129Xe 
imaging can sufficiently increase the SNR of HP TOF images, yielding more accurate 
perfusion recalculations and, potentialy, increased spatial resolution. 
 
5.2.2. Improvement of the designed pulse sequences 
 
 Multiple pulse sequence improvements can be implemented in order to significantly 
improve performance of the developed MRI techniques.  
 HP 129Xe TOF perfusion imaging was developed and tested using the conventional 
GRE pulse sequence with Cartesian k-space readout. Although this approach is quite simple 
and was mainly used in the field of HP 129Xe brain imaging, TOF mathematical theory 
cannot be applied without simplifications for data analysis in case of simple GRE readout. 
This fact results in potential overestimation of perfusion values if TOF times exceed the 
quasilinear region of the SNR time recovery curve.  
 In order to apply Eqn. [4-17] for perfusion calculation, the phase separation technique 
integration into readout is required. This will allow separation of HP 129Xe signals 
originating from different tissues with subsequent reconstruction of HP 129Xe TOF images of 
each tissue separately. In the case of brain imaging, phase separation will allow one to 
reconstruct HP 129Xe grey matter, white matter, soft muscle tissue, and blood TOF images. 
Each of these image sets can be further analysed using Eqn. [4-17] in order to achieve an 
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accurate perfusion map of each tissue. Although there are multiple different phase separation 
methodologies, implementation of iterative decomposition with echo asymmetry and least 
squares estimation (IDEAL)5-7 seems to be the most promising approach for HP 129Xe TOF 
perfusion imaging taking into account the necessity of working during the single breath hold. 
Furthermore, potential implementation of non-Cartesian k-space trajectories such as spiral 
trajectories can help in IDEAL implementation for TOF imaging due to the overall 
shortening of scan time. 
 The compressed sensing data acquisition techniques are of increasing interest in the 
MRI field, and have been recently implemented in the area of lung 19F imaging8. Briefly, this 
methodology relies on undersampling of the k-space data, preserving the spatial resolution of 
the resulting image. Compressed sensing allows significant scan time reduction compared to 
the conventional non-Cartesian k-space trajectories. Implementation of this technique will be 
extremely beneficial for OFCB lung imaging due to the potential of increasing the number of 
signal averages without substantial increase of the specific absorption rate. 
 
5.2.3. Software development 
 
 Although numerous studies were done using 19F and 129Xe MRI, there is still no clear 
vision of the appropriate image analysis procedure. Each project discussed above requires 
development of an accurate and appropriate data analysis algorithm which can be freely used 
for further human experiments. 
 The SNR time dependencies of 5-FU measured from the different organs were 
approximated using an exponential function. Although this model was sufficient for 
classification of two different colorectal adenocarcinomas, the complete mathematical model 
of 5-FU dynamics should be developed in order to improve the accuracy and sensitivity of 
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resistivity detection. Once a mathematical model is built, the dedicated CSI analyzing 
software should be developed and optimized prior to further implementation of this 
technique. 
 The SNR improvement caused by OFCB implementation for 19F imaging of the lungs 
has a potential to significantly improve diagnostics of pulmonary diseases. However, the 
MRI image must be recalculated into the pulmonological parameters such as ventilation 
volume, ventilation defect percentage, etc. The first step of every lung image analysis is 
image segmentation with subsequent clusterization. Currently, one of the most commonly 
used segmentation approaches is k-mean algorithm9. However, the k-mean segmentation 
algorithm tends to fail at processing images with low SNR (which are most of the 19F MRI 
images) and overestimates ventilated volume10. Therefore, development and implementation 
of the novel segmentation algorithm will be significantly beneficial for further 19F MRI 
imaging of the lungs. In addition, implementation of neural network segmentation similar to 
the work of Zha et.al.11 can revolutionize 19F lung MRI. 
 Lastly, dedicated software capable of reconstructing HP 129Xe TOF perfusion images 
using Eqn. [4-17] must be developed simultaneously with IDEAL readout implementation. 
Besides perfusion map recalculation, this software must be capable of 129Xe/1H brain image 
co-registration and realignment as well as of filtering and clusterization. In addition, in order 
to improve the HP 129Xe image quality, the k-space lines should be corrected with respect to 
the FA of the excitation pulse. For example, the HP 129Xe study described in Chapter 4 
utilized a FA of 20O resulting in approximately 6.1% loss of longitudinal magnetization for 
each subsequent line of k-space. Although the low-high arrangement of k-space can be used 
for increasing the image SNR, it also will result in some image blurring. Correction of the k-




5.2.4. Correlation of 5-FU uptake and DCE MRI 
 
 The study discussed in Chapter 2 demonstrated 5-FU retention detection in colorectal 
adenocarcinoma. Despite the promising results, further study of 5-FU retention and its 
correlation with tumor perfusion is needed. Generally speaking, different tumor types likely 
have different vascularization which will result in different perfusion of the tumors. Because 
of this, the different amounts of 5-FU will reach different tumor types per unit of time. This 
will affect 5-FU uptake by the tumor and, potentially, might affect 5-FU retention in the 
tumor. In order to evaluate the tumor perfusion effect on 5-FU retention, either DCE MRI or 
ASL MRI should be performed and the average perfusion value of the tumor should be 
correlated with the 5-FU tumor retention value.  
 For accurate retention detection, normalization of the 5-FU signal with respect to a 
known standard should be performed. This normalization will eliminate potential influence 
of the 5-FU relaxation effects on the measured 5-FU retention. In addition, an accurate 
modeling of the 5-FU time dynamics should be performed. 
 
5.2.5. Evaluation of a potential gravitational gas gradient of OFCB in human lungs 
 
Since OFCB is a slightly denser gas than PFP (ρC4F8 = 200 g/mol; ρC3F8 = 188 g/mol), 
the gas distribution in the lungs might be inhomogeneous. This gravitational gradient in the 
gas distribution might cause an image inhomogeneity once large amounts of gas is inhaled 
and, therefore, can potentially be observed on the images of the human lungs. Therefore, 
comparison of image homogeneities should be performed between the human lung images 
acquired using PFP and OFCB.  
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 In order to perform human lung imaging using OFCB, this fluorinated gas should be 
approved for human inhalation by Health Canada. Since OFCB is a non-toxic inert 
fluorinated gas, there should be no potential issues for getting all regulatory approvals for 








This thesis demonstrates multiple techniques that are aimed at technical improvement 
and practical application of multinuclear MRI, specifically 19F MRI and HP 129Xe MRI. The 
methodologies described in this thesis demonstrate the ability of multinuclear MRI to serve 
as a functional imaging modality in oncology, pulmonology, and neurology.  
Each technique developed during this work resolves at least one of the challenges 
previously associated with multinuclear MRI imaging. The ongoing image quality and data 
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